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ABSTRACT
Fynboh, Jessica Lynn. Development of a pilot educational seminar for the integrative medical
management of adults with anxiety. Unpublished Doctor of Nursing Practice scholarly
project, University of Northern Colorado, 2022.

Anxiety is a global disease that continues to rise. The COVID 19 global pandemic,
natural disasters due to climate change, war, and personal stressors continue to cause the steady
rise in anxiety worldwide. As many as 40 million Americans suffer from anxiety. A review of
standard anxiety treatments including selective serotonin reuptake inhibitors such as Prozac,
benzodiazepines such as Xanax, and cognitive behavioral therapy revealed they only provided
relief for approximately half of the patients treated. Over the past two years, provider colleagues
and their clients in an outpatient private practice where this educational seminar took place had
been increasingly expressing an interest in integrative methods for the management of adult
anxiety. This Doctor of Nursing Practice quality improvement pilot project aimed to address this
issue through creation of an online educational seminar presented to the nurse practitioners at a
small outpatient behavioral health clinic. Although inferential statistics were unable to be
conducted for this project, the results demonstrated that the participants in this small pilot study
showed a small increase in mean that we could infer as a trend toward increasing knowledge and
understanding. However, no significant changes were noted in provider attitudes toward
integrative healthcare. A limitation of this project included a small sample size from one
location.
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CHAPTER I
INTRODUCTION
Mental health is one of the leading causes of illness worldwide. Anxiety and depression,
the two most common mental illnesses, cost the global economy over a trillion dollars every year
(World Health Organization [WHO], 2022). Anxiety and depression can be co-occurring, and an
untreated anxiety disorder may be the underlying cause of many cases of depression (Anxiety
and Depression Association of America [ADAA], 2021). Anxiety disorders have a
hospitalization rate six times higher compared with other psychiatric disorders; as many as 40
million Americans or an estimated 18% of the population suffer from anxiety (ADAA, 2021).
Anxiety is an emotion most people feel to varying degrees in their life such as during an
exam or a job interview but an anxiety disorder can be a debilitating disease that causes
emotional distress, panic, isolation, and an increased risk for the development of depression and
suicidal ideation (National Institute of Mental Health (NIMH], 2018). In 2021, the Centers for
Disease Control and Prevention [CDC], 2022) reported that anxiety increased by 13% from
August to December 2020 (Jia et al., 2021). The number of adults with anxiety is expected to
climb with the continuation of the global COVID 19 pandemic and the increase in natural
disasters related to climate change, both significant stressors contributing to the prevalence and
intensity of anxiety across global populations (CDC, 2022).

2
Background
Current Treatment Options for the
Management of Adult Anxiety
Despite anxiety being recognized worldwide as a pressing health issue, standard
pharmacological treatments are only moderately successful and pose risks and undesirable side
effects for many patients. The most prescribed medications are in the selective serotonin
reuptake inhibitors (SSRIs) category, yet these drugs have a success rate of only 60-80% and
only half of patients prescribed a medication from this class achieve complete relief from their
symptoms (Garakani et al., 2020). Serotonin reuptake inhibitors also carry a significant amount
of side effects including weight gain, sexual dysfunction, insomnia, headaches, and
gastrointestinal upset (Stahl, 2021). Serotonin-norepinephrine reuptake inhibitors (SNRIs) are
also used to treat anxiety but carry an even greater risk of side effects including significant
sexual dysfunction, weight gain, elevated blood pressure, and discontinuation syndrome.
Discontinuation syndrome is a very uncomfortable side effect for clients that might include flulike symptoms, dizziness, nausea, and insomnia when missing a dose or trying to stop the
medication (Stahl, 2021). Older treatments for anxiety such as tricyclic antidepressants (TCAs)
and monoamine oxidase inhibitors (MAOIs) are reserved for treatment as a last step in most
cases due to safety concerns from side effects, lethality in overdose with TCAs, possible
hypertensive crisis with exposure to tyramine with MAOIs, as well as significant sexual side
effects and weight gain (Stahl, 2021).
Benzodiazepines work on the same receptors in the brain as alcohol does with similar
effects such as fatigue, lack of judgment leading to inability to drive and work, short term and
long-term memory loss, dependency, and withdrawal symptoms that could cause injury or death
(Lader & Kyriacou, 2016). Benzodiazepines have been used with caution in the treatment of
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anxiety disorders over the past decade but due to these significant side effects, their use has been
minimal.
Due to the above psychopharmaceuticals carrying a myriad of unpleasant and even lifethreatening side effects as well as the potential only partially to alleviate anxiety symptoms,
many people with an anxiety disorder will stop taking these medications, often against medical
advice (Burton et al., 2015). Burton et al. (2015) found that among 24,000 patients in a primary
care database prescribed medications to treat anxiety, approximately 28% discontinued use after
a single 30-day prescription. This was especially concerning because many of these medications
required up to 12 weeks to reach effectiveness (Stahl, 2021).
Increasing Demand for Alternative/
Complementary Treatments for
Adult Anxiety
According to The National Center for Complementary and Alternative Medicine
(NCCIH, 2018), integrative medicine combines conventional and alternative/complementary
approaches with an emphasis on the needs and preferences of the whole person rather than a
particular disease state. A study from Gannotta et al. (2018) noted integrative treatments were
not only sought by many patients as adjuncts to traditional management of anxiety in hospital
settings but an increasing number of providers also believed integrative treatments had the
potential to reduce stress and lower hospital costs. A survey conducted at Baylor University in
Texas revealed that 80% of resident physicians on a pediatric unit reported their patients used
alternative/complementary therapies and 90% believed their knowledge of integrative medicine
needed expansion (Gannotta et al., 2018). For this pilot project, alternative/complementary
referred to supplements or treatments not included in typical conventional treatments. The use of
alternative/complementary and conventional treatments was the basis of integrative treatment.
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Some alternative/complementary treatments for anxiety that have proven efficacious and
safe include supplementation with ashwagandha, chamomile, magnesium, passionflower, and
valerian. Ashwagandha and chamomile have been used for decades in the treatment of anxiety
and create a sense of calm and relaxation, and magnesium is a much needed and often deficient
nutrient that helps with multiple body processes as well as calming properties (Borrás et al.,
2021; Hieu et al., 2019; Lopresti et al., 2019; Rycroft-Malone & Tsai, 2018). Passionflower and
valerian are plant-based extracts that can provide relief from anxiety symptoms by themselves or
in conjunction with other conventional treatment methods (Borrás et al., 2021; Gibbert et al.,
2017; Shinjyo et al., 2020). In addition, non-pharmaceutical modalities such as biofeedback and
meditation have been used as alternative/complementary treatments for managing anxiety by
teaching individuals to recognize and control involuntary body processes such as heart rate,
creating a sense of feeling centered and grounded in the moment instead of dwelling in the worry
and unknown of the future (Arizteca et al., 2017; Bandelow et al., 2015; Goessl et al., 2017; Kim
& Kim, 2018; Saeed et al., 2019).
One reason why integrative treatment mght not be utilized as widely as conventional
treatment in the United States are conflicting methods of training and education among
providers. One way of training involves strict adherence to conventional psychiatry and medical
practices, while another form of training focuses on alternative/complementary treatment
methods with minimal crossover between the two approaches (Lake & Turner, 2017). As an
alternative to this dichotomy, integrative care focuses on blending conventional and
alternative/complementary treatments to look at the entire constellation of symptoms and provide
treatment based on a holistic view of the entire patient (Lake & Turner, 2017). Integrative
providers “make use of the full complement of therapies when constructing a plan of care for
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their patients” (Kreitzer & Koithan, 2019, p. 13). Gregory and Hardy (2022) highlighted the need
for better anxiety treatments by simply focusing on psychopharmacological options for primary
care advanced practice nurse practitioners, yet the research suggested these methods had a high
rate of treatment failure, indicating additional approaches outside of traditional methods of
treatment were called for (Garakani et al., 2020; Gregory & Hardy, 2022).
Many psychiatric mental health nurse practitioners echo these findings, noting a
continued rise of anxiety in the population. Over the past two years, provider colleagues and
their clients in the outpatient private practice where this educational seminar took place have
increasingly expressed an interest in integrative methods for the management of adult anxiety.
Several practitioners in this practice carry certification in integrative mental health from the
Integrative Psychiatry Institute in Boulder, Colorado. However, most of the providers in this
practice do not have training or knowledge of integrative treatment methods and rely heavily on
those with integrative expertise to guide their decision-making.
Provider Receptivity to the Use of
Alternative/Complementary
Treatment Options
Receptivity and knowledge of alternative/complementary treatments continue to be a
barrier for more widespread integration of this treatment into medical practices. A study from
Fletcher et al. (2017) in the Veterans Administration (VA) healthcare service was conducted to
assess provider and administrators’ perceptions of alternative/complementary treatment. The
study found that while the VA did promote alternative/complementary treatments, the adoption
and use of these treatments were not represented in use of the treatments. The study found that
even though over 50% of active-duty service members utilized alternative/complementary for
multiple conditions to include pain management, mental health management, and barriers to
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treatment including provider knowledge of referral within the system, personal provider
knowledge and attitude toward alternative/complementary treatment were not able to meet the
demands for more access to this treatment method (Fletcher et al., 2017).
Abbott et al. (2009) conducted a study using a modified version of the Integrative
Medicine Attitude Questionnaire to measure medical students’ attitudes toward
alternative/complementary treatment. Recruitment for this study was sent to every medical
college across the United States. This study found the medical students surveyed had a favorable
attitude toward the idea of alternative/complementary medicine but not a favorable view of use
of alternative/complementary treatments in practice (Abbott et al., 2009).
Attitude toward the use of alternative/complementary plays a role in its use and even
those who might view the idea of this treatment as positive, implementation into practice has not
been equal (Abbott et al., 2009; Fletcher et al., 2017).
Existing Practice Protocols for the
Management of Adult Anxiety
Currently, there is a lack of practice protocols or algorithms designed to help providers
navigate the full spectrum of treatment options for adults with anxiety. Instead, many providers
rely on conventional psychopharmacologic guidebooks or websites such as those from the
American Psychiatric Association (n.d.) whose practice guidelines include standard treatments.
Of note, no current practice guidelines or protocols for alternative/complementary treatments for
anxiety were on the APA (2013) website but they did have alternative/complementary guidelines
for other mental health disorders such as depression. Even within the federally funded NCCIH
(2018), there was a distinct lack of guidance for alternative/complementary treatments for
anxiety to help providers with or without integrative training. In the book Integrative Nursing
(Kreitzer & Koithan, 2014), the section devoted to anxiety provided a “tier” table for anxiety.

7
Unfortunately, this table lacked specific dosing and guidelines, rendering it useless to someone
unfamiliar with integrative medicine and further limiting the use of integrative approaches to
treatment for anxiety (Kreitzer & Koithan, 2014). Traditional approaches rely heavily on
medications and therapy but often exclude alternative/complementary treatments for providers to
guide their prescribing (APA, 2013; Kreitzer & Koithan, 2014; NCCIH, 2018; Stahl, 2021).
Therefore, many mental health providers are limited in their ability to provide comprehensive
and effective care to this population.
Statement of the Problem
Anxiety is a global issue that is estimated to increase. Anxiety can lead to lost wages,
depression, and suicide (WHO, 2022). The need for a wider variety of safe and effective
treatments for adult anxiety is needed to reduce anxiety symptoms in the population (ADAA,
2021). There is a lack of guidelines or protocols for advanced practice providers to consult while
treating adult anxiety that incorporates both conventional and alternative/complementary
approaches based on both evidence and patient demand (ADAA, 2021; CDC, 2022; NCCIH,
2022). Attitudes toward alternative/complementary, as well as a lack of knowledge and
resources, leave a gap in care that might inhibit use of these treatments. This might lead to
hesitation on the part of providers in utilizing these methods despite their potential to alleviate
symptoms and improve quality of life (Abbott et al., 2009; Gregory & Hardy, 2022).
Purpose of the Project
This Doctor of Nursing Practice (DNP) scholarly quality improvement pilot project was
the development of an online educational seminar presented to nurse practitioners at an
outpatient mental health private practice and evaluated if the online educational seminar
enhanced their understanding, knowledge, and attitudes toward the use of alternative/
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complementary treatments for adults with anxiety, which would create an integrative approach to
treating adults with anxiety in the outpatient setting. Since the providers in this practice were all
versed in conventional treatments for anxiety, this online educational seminar provided
alternative/complementary treatment methods that increased their knowledge and comfort in
offering these treatments blended with conventional treatments, which is the basis of integrative
care.
Need for the Project
The increase in anxiety and lack of integrative practice knowledge created a clear gap in
treatment for this continued rising global issue that was filled by an online seminar that educated
providers on alternative/complementary treatments. For nurse practitioners already versed in
conventional treatment methods for anxiety, a wider scope of treatments to help alleviate the
global burden provide a broader scope of practice tools to address this gap.
Project Questions
This DNP scholarly quality improvement pilot project addressed the following questions:
Q1

Will an educational seminar focused on integrative treatment options for anxiety
improve mental health provider’s awareness and knowledge regarding two
common integrative treatment options for adults with anxiety (meditation and
ashwagandha)?

Q2

Will participation in the educational seminar on integrative treatment options for
anxiety impact the attitudes and receptivity of mental health providers towards
using integrative approaches in the future with adult patients seeking treatment for
anxiety?
Objectives of the Project

The objectives of the project were to
1.

Synthesize current evidence and practice expertise from integrative providers in
the outpatient mental health private practice to develop an online educational
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seminar of two alternative/complementary treatments for the adult population
with anxiety.
2.

Develop and conduct an online educational seminar to be given to the advanced
practice providers at the identified private practice.

3.

Evaluate the advanced practice providers attitudes, receptivity, knowledge and
understanding towards utilizing integrative treatment approaches for adults with
anxiety before and after participation in the online educational seminar

4.

Develop a template for further educational seminars to increase and expand
knowledge of integrative treatment methods.
Summary

Anxiety is an increasing global disease that is estimated to increase. Climate change, the
COVID-19 global pandemic, and wars continue to increase the global burden of anxiety.
Existing treatment methods are not sufficient alone to treat all individuals affected by anxiety
and an integrative treatment approach could help to increase options in treatment for providers
and individuals.
Definition of Terms and Acronyms
Ashwagandha: An herb from India or Nepal commonly utilized to promote relaxation and a
feeling of calm (Consumerlab, 2022).
Benzodiazepines: A class of medications typically used for their tranquilizing properties
(Merriam-Webster, n.d.-a).
Bio Feedback: Learning to make unconscious body processes, such as the rate of the heart,
perceptible to the conscious mind to help control them (Merriam-Webster, n.d.-b).
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Cognitive Behavioral Therapy (CBT): Psychotherapy that combines cognitive as well as
behavioral therapy to help to identify and change maladaptive thoughts and behaviors
(Merriam-Webster, n.d.-c).
Dietary Supplement Verification Program: A nonprofit scientific organization that tests
supplements for safety and efficacy to help ensure quality products for the consumer
(United States Pharmacopeial Convention, n.d.).
Dissemination and Use of Research Evidence for Policy and Practice (DUREPP):
Abbreviation used in this paper in reference to this model.
Integrative treatment: Combining conventional and complementary/alternative approaches to
treat the whole person (NCCIH, 2018).
L-Theanine: A product of green and black tea that is considered a non-essential amino acid
(Consumerlab, 2022).
Monoamine Oxidase Inhibitors (MAOIs): Antidepressants that increase monoamine in the
brain by inhibiting its action (Merriam-Webster, n.d.-d).
Selective Serotonin Reuptake Inhibitors (SSRIs): Antidepressants that inhibit the inactivation
of serotonin in the brain, making it more available for use in the brain (Merriam-Webster,
n.d.-e).
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs): Drugs that inhibit the inactivation of
serotonin and norepinephrine, making them more available for use in the brain (MerriamWebster, n.d.-f).
Tricyclic Antidepressants (TCAs): Antidepressants that inhibit the action of catecholamines,
but do not inhibit actions of monoamines (Merriam-Webster, n.d.-g).
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CHAPTER II
REVIEW OF THE LITERATURE AND
THEORETICAL FRAMEWORK
A review of the literature regarding integrative and standard treatments for anxiety was
conducted between October 2021 and April 2022 using the following databases: Cumulative
Index to Nursing and Allied Health Literature (CINHAL), PsycINFO, and PubMed. The search
terms used were “anxiety,” “integrative treatment,” and “adult.” The Boolean operator “AND”
was used to connect these terms. To narrow the list and find more specific integrative literature,
the words “dietary supplements” and “medicinal plants” were also added to “anxiety,”
“integrative treatment,” and “adult” with continued use of the Boolean operator “AND.” Based
on most used integrative treatment options for adult anxiety referenced in the literature review
and the NCCIH (2022), the following additional terms were added to the search: “l-theanine,”
“ashwagandha,” “magnesium,” “omega-3”, “meditation,” “relaxation,” and “biofeedback.” Each
of these terms was added to the original terms (“anxiety-integrative-treatment-adult”) with the
Boolean operator “AND.” Inclusion criteria included information within the last five years, adult
participants, randomized control trials, meta-analysis, and systematic reviews. Exclusion criteria
included articles older than five years, low-level evidence, or those that focused on treatments for
depression only. Findings from this literature search are detailed in the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses diagram in Appendix A.
Twenty-three articles were included in this review. Integrative studies are historically of
lower quality so randomized placebo-controlled trials, meta-analysis, and systematic reviews
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were included to utilize the highest quality evidence. This review provided the following
evidence: one randomized double-blind placebo-controlled study and a systematic review
concerning ashwagandha (Borrás et al., 2021; Lopresti et al., 2019); one meta-analysis and one
systematic review for chamomile and one practice recommendation (Hieu et al., 2019; RycroftRycroft-Malone & Tsai, 2018); one small, randomized placebo controlled study concerning ltheanine and a double blind randomized placebo control trial (Hidese et al., 2019; Sarris et al.,
2019); two systematic reviews for omega-3 (Deane et al., 2021; Su et al., 2018); one post hoc
analysis of an randomized control trial and one systematic review for magnesium (Boyle et al.,
2017; Noah et al., 2021); seven studies for meditation/relaxation/biofeedback including two
meta-analysis for meditation, one systematic review and meta-analysis and one meta-analysis for
relaxation (note Bandelow et al. was used for meditation and relaxation), one meta-analysis and
one small academic study for bio feedback, and one meta-analysis and one systematic review
and meta-analysis for exercise (Arizteca et al., 2017; Aylett et al., 2018; Bandelow et al., 2015;
Goessl et al., 2017; Kim & Kim, 2018; Kligler et al., 2016; Saeed et al., 2019); one meta-analysis
and one systematic review for standard treatment (Bandelow et al., 2015; DeMartini et al., 2019);
one systematic review and meta-analysis and one literature review for Cognitive behavioral
therapy (Daitch, 2018; van Dis et al., 2020); and one developmental research article regarding
the Integrative Medicine Attitude Questionnaire (Schneider et al., 2003). Appendix B provides
the complete Table of Evidence, which presents summaries of each article.
Historical Background
Anxiety
Since ancient times, philosophers have been writing about and recommending treatments
for anxiety. In 50 BC, Roman philosopher Cicero wrote of sollicitado (worry) and angor
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(anxiety) as disorders between a troubled mind and body in his book The Tusculan Disputations
(Crocq, 2015). Some philosophers thought anxiety came from the finite mind trying to come to
terms with the infinite. The recommendation to relieve symptoms was to focus on the now
instead of worrying about the future (Crocq, 2015). Indeed, many of the treatments for what the
ancients referred to as molestia (affliction) are much of the basis of our therapies today such as
cognitive behavioral therapy (CBT).
In the 18th century, anxiety symptoms were often lumped together with symptoms of
melancholy (depression) and were not treated as a separate illness. It was not until the 19th
century that anxiety emerged as a diagnosis of its own (Crocq, 2015). Referred to as neuroses or
neurasthenia, symptoms included anything from panic and hysteria to phobias and depression.
With the creation of the Diagnostic and Statistical Manual (DSM) in 1952, psychoneurotic
disorders were classified with the chief symptom—anxiety (Crocq, 2015). The current
Diagnostic and Statistical Manual V (DSMV; APA, 2013) contains an entire chapter addressing
anxiety disorders. In recent decades, treatments for anxiety consisted of a combination of some
form of psychotherapy and a psychopharmacological agent such as a selective serotonin reuptake
inhibitor (SSRI). Success rates of therapy and medication management of anxiety have
historically been between 60-80% (Garakani et al., 2020).
Integrative Nursing Care
Integrative approaches in nursing have been evident since the profession's inception with
Florence Nightingale leading the way by connecting the environment and the person in terms of
healing and wellness (Kreitzer & Koithan, 2019). Nursing has traditionally considered the whole
person rather than just the illness a person might be suffering from. Integrative care uses
evidence from multiple sources including those from alternative/complementary health,
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traditional psychopharmacological treatments, therapies and therapeutic relationships, and
collaborative care across health care that focuses on treating the whole person (Kreitzer &
Koithan, 2019).
Despite anxiety being a known ailment since ancient times, treatment for anxiety has
primarily remained the same. Therapeutic treatments such as CBT, with co-occurring
psychopharmacological treatment, remain the standard of care despite low rates of remission of
symptoms; these treatment options can only be initiated by nurses with prescribing authority
(Kreitzer & Koithan, 2019). Utilizing an integrative nursing approach to treat anxiety holds the
potential to expand upon current treatments and increase remission rates in adults with anxiety.
Treatment Options for Adults with Anxiety
Despite the increased interest and research in integrative approaches, there are no
standard practice protocols for the integrative management of adult anxiety. The field of
integrative treatments was vast so there were limits on what was included in this literature
review. The most common conventional clinical practices for the treatment of anxiety and
alternative/complementary treatments with the highest levels of evidence were included in this
review to evaluate if the evidence supported clinical practice. For organization of this literature
review, evidence for each treatment was categorized and synthesized.
Concerns among providers regarding alternative/complementary treatments along with
common sense practices were considered and addressed. It is estimated that over 21% of people
in the United States use some type of herbs or supplements to help with various symptoms from
pain management to depression and anxiety (Phutrakool & Pongpriul, 2022). With conventional
medication, safety is assumed based on the government regulations for drug approval from the
Federal Drug Administration (Curtis & Gaylord, 2005). However, safety concerns regarding

15
conventional treatment included drug errors, patient compliance, polypharmacy issues, drug to
drug interactions that could account for serious health issues to include death, highlighting the
assumed “safety” of conventional medications has many factors and is not as straightforward as
some in the medical community might assume (Curtis & Gaylord, 2005).
Standard Pharmacological Treatments
for Anxiety
DeMartini et al. (2019) reviewed standard treatments for anxiety disorders and
determined that SSRIs such as Lexapro (Escitalopram), Paxil (Paroxetine), and Zoloft
(Sertraline) remained the first choice for pharmacological treatment of anxiety. The authors
noted that side effects for this class of medications included nausea, insomnia, diarrhea,
decreased sexual function and ability, weight gain, sedation, significant interactions with other
medications, and possible cardiac problems in older adults with some SSRIs. Serotoninnorepinephrine reuptake inhibitors such as Effexor (Venlafaxine) and Cymbalta(Duloxetine)
were also considered first-line treatments but they carried the risk of side effects such as weight
gain, significant gastrointestinal distress, hypertension, and discontinuation syndrome. Serotoninnorepinephrine reuptake inhibitors might help reduce anxiety in those who have not achieved an
adequate response with an SSRI (Bandelow et al., 2015; Stahl, 2021).
Second line medications included Buspirone, a serotonin receptor partial agonist,
benzodiazepines such as Xanax (Alprazolam) and Ativan (Lorazepam), and anticonvulsants
such as Lyrica (Pregabalin) and Gabapentin (Neurontin; Bandelow et al., 2015). Buspirone
could cause significant side effects such as dizziness and insomnia, whereas benzodiazepines
could cause dependency, memory issues, and dangerous withdrawals that could be lifethreatening. Pregabalin, an anticonvulsant, should be avoided in patients with renal disease as
side effects such as sedation, dizziness, and significant swelling in extremities could occur
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(DeMartini et al., 2019). The anticonvulsant and nerve pain medication Gabapentin might also be
used but has sedating qualities that some patients cannot tolerate (Stahl, 2021). Benzodiazepines
reduce symptoms of anxiety and panic but the use of these medications as a chronic treatment
could lead to dependency, tolerance issues, and dangerous withdrawal side effects (Bandelow et
al., 2015).
Third-line medications included atypical antipsychotics such as Seroquel®(Quetiapine),
antihistamines such as Vistaril (Hydroxyzine), and TCAs such as Tofranil (Imipramine;
DeMartini et al., 2019). Antipsychotics carry several significant side effects including significant
weight gain, an increase in cholesterol and blood sugar levels, extreme fatigue, and movement
disorders such as extrapyramidal symptoms and tardive dyskinesia, which could be permanent
and resembles an individual with Parkinson’s disease. Blood work needs to be monitored to
observe cholesterol and blood sugar levels. Stahl (2021) recommended that BMI and waist
circumference be monitored every three months, then quarterly after six months, and possible
nutrition and or weight management for weight gain caused by the medications.
Hydroxyzine is an antihistamine that has anxiolytic properties and is used mainly for
acute anxiety with side effects including sedation, dry mouth, and problems with urination
(DeMartini et al., 2019). Sedation could be quite common with hydroxyzine, which could be
problematic and could limit its use, as well as a possibility of prolongation of QTC interval,
which could lead to heart abnormalities (Stahl, 2021). Tricyclic antidepressants are an older
antidepressant with antianxiety effects but carry significant side effects such as arrhythmias,
constipation, vision difficulties, and extreme lethality with overdose (DeMartini et al., 2019).
Beta-blockers such as Inderal (Propranolol) can effectively treat acute anxiety but both
Buspirone and propranolol could carry side effects such as orthostatic hypertension, dizziness,
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and dry mouth (Bandelow et al., 2015). While many of these treatments could be effective for
some of the population, as discussed previously, side effects such as weight gain, sedation,
sexual dysfunction, and blood level changes in cholesterol and glucose leave a gap for other
treatments an integrative approach might fill.
Cognitive Behavioral Therapy
Standard practice guidelines for anxiety include a mix of psychopharmacology and
psychotherapy (van Dis et al., 2020). Cognitive behavioral therapy is the most common nonpharmacologic therapy for anxiety (van Dis et al., 2020). A systematic review and meta-analysis
from van Dis et al. (2020) analyzed the long-term effects of CBT in anxiety treatment. Sixty-nine
randomized control trials with over 4,000 patients were evaluated. Some of the studies were of
low quality; however, data regarding CBT long-term therapy showed efficacy for reduction in
anxiety for up to 12 months following cessation of therapy (van Dis et al., 2020).
A literature review by Daitch (2018) regarding CBT found that although it was
considered the “gold standard” therapy for anxiety, many studies found that after therapy had
ended, 42-58% of patients reported they had maintained a consistently high level of functioning
and cessation of anxiety symptoms. This mirrored the van Dis et al. (2020) study that only
reviewed functioning at 12 months out but not on a long-term scale, warranting further
investigation (Daitch, 2018). Cognitive behavioral therapy could be an effective tool in the
treatment of anxiety; however, it does require a time commitment. Many therapists who offer
CBT might not be covered by insurance, requiring the consumer to pay out of pocket, which
could be a barrier to some for this treatment methodology. PsychologyToday (n.d.) reported that,
on average, therapists who take insurance are a lower percentage due to low reimbursement costs
from insurance companies, making it harder for them to run a viable practice taking insurance.
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Exercise/Physical Activity
Exercise has long been a standard treatment for the reduction of anxiety symptoms. A
meta-analysis review of 37 studies with over 42,000 participants showed that exercise could have
a small to moderate effect on reducing anxiety and mood symptoms (Kligler et al., 2016).
Another systematic review from Aylett et al. (2018) showed that exercise was indeed helpful in
reducing anxiety symptoms. The authors found higher intensity exercise had more benefits for
anxiety, but that before recommending exercise, patients should be evaluated on an individual
basis to determine safety (Aylett et al., 2018). Since the benefits of physical activity have been
linked to the prevention of chronic diseases such as cardiovascular disease and help with weight
loss, adding exercise a patient could tolerate as a treatment for anxiety might also have a
positive, whole person impact (Aylett et al., 2018). Aerobic exercise showed the most benefit
with at least 30 minutes of aerobic exercise three to five times a week for the most relief of
anxiety symptoms (Kligler et al., 2016).
Alternative/Complementary Treatment
Options for Anxiety
Alternative/complementary medicine, including herbs, is not regulated in the same way
as conventional medications. These are regulated as a “food” rather than a medicine so
standardization among products could be problematic (Curtis & Gaylord, 2005). These products
must prove to the Food and Drug Authority that they are expected to be safe (Curtis & Gaylord,
2005); however, they are not required to prove this safety in clinical trials such as conventional
medicines. Pharmavite®, who distributes supplements under the name of Nature Made®, has
become a trusted brand for consumers over the past 35 years.
The Nature Made brand is widely distributed and Pharmavite was the first supplement
distributors to be certified under the United States Pharmacopeias Convention’s (n.d.) Dietary
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Supplement Verification Program. This program created standards and guidelines to ensure
supplement safety and quality control; those that do not meet standards are not approved. The
parent company of Pharmavite is the drug company Otsuka Pharmaceuticals Co. LTD, which
makes many of the conventional medications providers use and might be more comfortable with
prescribing (Bonakdar, 2010). Another way to help ensure safety and alleviate provider fears
among supplements and herbs is through third-party organizations such as Consumerlab (2022)
or Natural Medicines™ (n.d.) that do independent testing of products to ensure the purity,
strength, and the product is what it says it is. They list the verified products on their websites and
providers could pay a fee to subscribe to these websites. The federally funded NCCIH (2022) has
a web page that anyone can access that lets the consumer know about any recalls, alerts, and
advisories, as well as fact sheets for the use of supplements and herbs.
Ashwagandha
Ashwagandha or Withania somnifera is an herb originally grown in India (Consumerlab,
2022). A systematic review of clinical trials from 2010-to 2020 demonstrated a high level of
safety and efficacy of ashwagandha while also highlighting its limitations (Borrás et al., 2021).
This review found ashwagandha is among the top three supplements showing positive clinical
trial results for anxiety and insomnia (Borrás et al., 2021). Lopresti et al. (2019) conducted a
randomized, double-blind, placebo-controlled study, indicating ashwagandha lowered Hamilton
Anxiety Scale scores by 41% compared to the placebo group. Doses of ashwagandha used in the
studies ranged from 240mg two times a day to 300mg two times a day vs. placebo. Typical
dosing for ashwagandha is 300mg to 600mg a day as recommended by a recent clinical guideline
review of alternative/complementary evidence from The World Federation of Societies of
Biological Psychiatry and Canadian Network for Mood and Anxiety Treatment Task Force

20
(Sarris et al., 2022). Overall, the studies on ashwagandha were of smaller size but the risk of side
effects was shown to be very low to minimal. The volume of studies reviewed in the systematic
reviews and meta-analysis also strengthened the evidence that ashwagandha could be efficacious
in treating anxiety in adults while also demonstrating a high level of safety (Borrás et al., 2021;
Lopresti et al., 2019).
Overall, the evidence suggested ashwagandha could be an effective and safe treatment for
anxiety. Kuhn and Winston (2008) cited that with recommended use, ashwagandha did not
demonstrate toxicity. Borrás et al. (2021), in an updated review of alternative/complementary
treatments for insomnia and anxiety, found ashwagandha was among the top three supplements
showing positive clinical trial results for anxiety and insomnia. Lopresti et al. (2019) showed a
significant reduction (41%) in anxiety compared to the control group that showed a 21%
reduction in anxiety on the Hamilton Anxiety Scale.
Typical dosing for ashwagandha in the studies in this literature review ranged from
480mg a day in two split doses to 1000mg daily for stress and anxiety (Borrás et al., 2021;
Lopresti et al., 2019). The government-funded NCCIH showed dosing and precautions for
ashwagandha uses on Medline Plus (2022), which is a reliable tool all clinicians can access; it
can be used in the development of an online educational seminar along with the evidence
included in this review and other peer reviewed, published books or articles.
Ashwagandha is considered safe to be taken daily in 12-week periods. Common side
effects could include gastrointestinal symptoms; however, there have been rare reports of liver
damage so those with reduction in liver function should be monitored and ashwagandha should
be used with caution in this population. There are no know food interactions but providers need
to know about any drug-to-drug interactions between ashwagandha and any conventional

21
medicines or other alternative/complementary treatments. Medline Plus (2022) suggested that
anyone taking antidiabetics or antihypertensives monitor their blood sugar levels and blood
pressures as ashwagandha might lower these and a reduction of medications might be warranted
in consult with a primary care provider. Ashwagandha should also be used with caution in those
taking thyroid replacement as it might increase thyroid hormones and doses of thyroid
medications might need to be lowered. Ashwagandha could increase fatigue and slow breathing
so it should be used with caution in those taking benzodiazepines and central nervous system
depressants. Ashwagandha should not be used in someone who takes immunosuppressants as it
might increase an immune response. As with most medications or supplements, it should be
avoided during pregnancy or breast feeding and it might need to be stopped prior to a surgical
procedure due to central nervous system depression (Borrás et al., 2021; Lopresti et al., 2019).
Magnesium
Magnesium is an essential vitamin and deficiency is common in the general population
(Razzaque, 2018). Magnesium works with more than 600 enzymes and is the fourth most
abundant nutrient in the body. It plays multiple roles in the body including skeletal,
cardiovascular, and metabolic processes (Razzaque, 2018). A systematic review from Boyle et
al. (2017) also found that magnesium could reduce anxiety with standard deviations ranging
from 0.7 to 6.0 in the studies that looked specifically at anxiety. Of the eight studies reviewed in
this meta-analysis, no significant adverse effects were noted; however, in many studies,
magnesium was combined with B6 and or California poppy and only two of the studies used
magnesium as monotherapy. This review did note that much of the existing evidence was of poor
quality and higher-quality studies need to be done (Boyle et al., 2017). Noah et al. (2021)
conducted a large, randomized control trial that found magnesium might improve anxiety and
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depression symptoms without the augmentation of B6. Mean anxiety scores on the Depression
Anxiety Stress Scale when comparing magnesium with B6 vs. magnesium alone showed a
decrease from severe anxiety to mild near-normal anxiety levels (Noah et al., 2021). Multiple
sources supported the use of magnesium 400mg daily to treat anxiety with the added benefit that
most people are nutritionally deficient in this important vitamin (Boyle et al., 2017; Noah et al.,
2021; Razzaque, 2018).
Valerian
Valerian is a plant native to several places including North America, Europe, and Asia.
Valerian is often used for its anxiolytic and sedation properties to help with anxiety symptoms; it
is supplied in capsule form and typically prescribed in divided doses of 150mg to 500mg a day
(Kuhn & Winston, 2008). A systematic review from Borrás et al. (2021) found valerian has
anxiolytic properties among both male and female adults. Among the 13 reviewed studies, the
overall result of Valerian on anxiety was positive; however, more clinical studies should be
conducted (Borrás et al., 2021). Another systematic review from Shinjyo et al. (2020)
demonstrated that Valerian could also be used to treat anxiety. In eight studies with over 500
patients, valerian was shown to be safe. The authors postulated that inconsistent results from
anxiety trials in the past might be due to inconsistencies in the quality of herbal extracts used. As
stated previously, third-party websites that verify herbs and supplements are available to
providers along with integrative certifications to help with guiding patients in obtaining highquality and tested herbs and supplements.
Chamomile
Chamomile is derived from a flower in the Asteraceae family. For decades, this botanical
has been safely used in tea for anxiety and sleep (Consumerlab, 2022). A large meta-analysis and
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review found chamomile could be a safe and affordable option for treating anxiety (Hieu et al.,
2019). Chamomile was used in multiple forms throughout the studies in the meta-analysis and all
forms showed improvement in anxiety symptoms on multiple scales including Hamilton Anxiety
Rating Scale, Generalized Anxiety Disorder Assessment-7, Beck Anxiety Inventory Scale,
Psychological Well-being Score, and Clinical Global Impression Severity. Rycroft-Malone and
Tsai (2018) conducted a systematic review of the literature and found that chamomile was
efficacious in treating mild to moderate anxiety symptoms as well as being well-tolerated by
most patients. Typical dosing for chamomile for anxiety is 300mg capsules four to six times a
day (Kuhn & Winston, 2008).
L-Theanine
L-Theanine is a non-essential amino acid extract from green and black teas
(Consumerlab, 2022). L-Theanine is often used for reduction of anxiety and improved focus and
concentration. Findings from Hidese et al. (2019) indicated that L-theanine improved anxiety in
adults. Scores on multiple scales including the Self Rating Depression Scale (SDS), the State
Trait Anxiety Scale (STATI), and the Pittsburgh Sleep Quality Index (PSQI) showed a
significant reduction in anxiety (Hidese et al., 2019). This study recorded no adverse effects. A
double-blind placebo-controlled study by Sarris et al. (2019) found no difference between
placebo and L-Theanine at doses of 450-900mg daily in reduction of anxiety symptoms on the
Hamilton Anxiety Scale. For anxiety, the typical dosing for L-Theanine is 200mg before a
stressful event (Consumberlabs, n.d.).
Omega-3
Omega-3 polyunsaturated fatty acids are essential nutrients mainly obtained through diet
such as the ingestion of fish (Su et al., 2018). Typical dosing for omega-3 is 1 to 10 grams a day

24
in divided dosing (Kuhn & Winston, 2008). Despite widespread use of omega-3 supplementation
in the psychiatric community for depression and anxiety, two large meta-analyses had conflicting
data regarding efficacy in preventing anxiety symptoms. Deane et al. (2021) reviewed 31 trials
from 2016 to 2019 but were unable to find any positive benefit in adding omega-3
supplementation for anxiety. Su et al. (2018) examined 19 studies and found omega-3 might help
reduce general anxiety symptoms but further high-quality studies were needed (Su et al., 2018).
Passionflower
Passionflower is a vine plant native to many regions at tropical and non-tropical
temperatures. For centuries, passionflower has been medicinally used for anxiety symptoms in
tea and other forms. Typical dosing of the dried herb is one to two grams three times a day
(Kuhn & Winston, 2008). Borrás et al. (2021) found passionflower could effectively treat
anxiety. In the studies reviewed by Borrás et al. (2021), passionflower did indeed reduce anxiety
if used at a consistent dose. A randomized control trial found that after a 12-week treatment
course with dried herb passionflower, there was a significant decrease in anxiety symptoms with
only three reports of fatigue as a potential side effect and an overall improvement in anxiety
(Gibbert et al., 2017).
Meditation, Relaxation Therapy, and
Biofeedback
Meditation has been a long-used practice in many cultures. There is no agreed-upon
definition of meditation but it is generally defined as practices to induce states of self-awareness,
relaxation, and harmony (Bandelow et al., 2015). Bandelow et al. (2015) found mindfulnessbased meditation to have a higher effect size for reducing anxiety treatments compared to
traditional CBT. Saeed et al. (2019) conducted a large review of multiple meta-analyses and
systematic reviews and found mindfulness-based meditation could improve anxiety symptoms.
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While the effect of mindfulness-based meditation is not dependent on the number of sessions,
there is sustained improvement in anxiety symptoms with using meditation for an average of 27
weeks. There was no evidence by Bandelow et al. (2015) or Saeed et al. (2019) that meditation
could be harmful. Therefore, it could be recommended as a possible effective tool for anxiety
reduction in adults.
Meditation has been a long-used practice in many cultures. Bandelow et al. (2015) found
meditation had a higher effect size for reducing anxiety treatments compared to traditional CBT.
There are many types of meditation but all have certain elements in common. A patient needs a
quiet place, free of distractions where one can feel comfortable and focus attention on bodybased functions, such as breathing, to help center and calm the mind to reduce anxiety and stress
(NCCIH, 2022). Saeed et al. (2019) recommended mindfulness-based meditation could be used
as adjunctive treatment or in mild cases a stand-alone treatment for reducing anxiety. Kreitzer
and Koithan (2014) observed that meditation worked for reducing stress and anxiety by allowing
the mind to be aware of conscious thoughts and/or more aware of physical responses to anxiety,
which could reduce symptoms simply by recognition within.
Mindfulness-based meditations include being rooted in the moment and viewing self and
feelings in a non-judgmental manner to increase comfort and gain experience to improve anxiety
symptoms (Kreitzer & Koithan, 2014). Mind-body therapies such as meditation are included in
every tier of the Anxiety Tier Table as adjunctive treatment to anxiety (Kreitzer & Koithan,
2014). Saeed et al. (2019) reviewed meta-analysis, randomized control trials and systematic
reviews that demonstrated that mindfulness-based meditation practices could be used daily with
no harm to patients over years. Daily meditation could be safely added to conventional and or
alternative/complementary treatments to enhance and increase efficacy of those treatments
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(Saeed et al., 2019). Bystrisky et al. (2022) recommended mindfulness-based meditation to
relieve anxiety as they were likely to be beneficial with no harm to clients.
No prescribed length of time is recommended for mindfulness-based meditation; instead,
it is based on client comfort and reduction in anxiety symptoms. Generally, this individual, safe
practice could expand and grow with time and practice. Clinicians could help guide clients by
providing them with basic skills such as deep breathing, focusing attention within, letting go of
outside distractions, and being non-judgmental and open while practicing these skills (Bystrisky
et al., 2022).
Relaxation therapy can be viewed as another method of meditation. Relaxation therapies
are varied and include things such as progressive muscular relaxation and mindfulness-based
therapy. The overall goal for all relaxation therapies is to use relaxation to achieve a state of
anxiety relief. A large systematic review and meta-analysis found that implementing relaxation
therapy could be a valuable strategy for reducing anxiety (Kim & Kim, 2018). Bandelow et al.
(2015) found relaxation therapies were more effective than individual or group therapies
typically used in the treatment of anxiety. Due to the low risk of side effects, meditation and
relaxation therapy could be used as adjuncts with pharmacological, therapeutic, and/or
supplemental treatments, making both a safe and effective recommendation for the reduction of
adult anxiety.
Biofeedback is a form of stress reduction through regulation of certain biological
measures such as heart rate or breathing (Goessl et al., 2017). Biofeedback is a way to train an
individual to notice involuntary processes and to control or manipulate these processes through
focus and calming techniques to reduce anxiety and create a sense of calm (Goessl et al., 2017).
A meta-analysis from Goessl et al. (2017) indicated biofeedback might help to reduce anxiety
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and stress (Hedges g =0.81). Another randomized control trial-tested biofeedback techniques on
adults at a university to look at the efficaciousness of utilizing this method to help with stress and
anxiety students experience in academia. The study found a six-week course of training and
biofeedback reduced anxiety and improved academic success (Arizteca et al., 2017).
In conclusion, evidence suggested patients could use any or all these meditation
techniques to help with reduction in anxiety symptoms. In mindfulness-based practices, there
was no evidence of harm and all three interventions could be implemented by a patient in their
own setting or under the supervision of a healthcare provider to possibly reduce anxiety
symptoms.
Marijuana
Legalization of marijuana in the United States as of the writing of this document included
19 states; Washington. D.C., and Guam (Hansen et al., 2022). Since the legalization of
marijuana, studies have been ongoing in relation to benefits of use. Marijuana and research in its
use with anxiety are ongoing and as such, it was not included as a treatment method for this pilot
project. In the book Marijuana and Mental Health by Michael T Compton (2016), a significant
number of studies showed no positive increase in anxiety and anxiety related symptoms to
warrant its use. As further studies are created and reported, this might change in the future.
However, marijuana treatment for anxiety needs continued research before recommendations can
be made with its use in the adult population with anxiety.
Synthesis
Anxiety is a global concern and the number of adults with anxiety is expected to climb in
the coming years (CDC, 2022). Standard practice for anxiety affords some relief with
medications such as SSRIs and therapies such as CBT and exercise (Aylett et al., 2018;
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Bandelow et al., 2015; Daitch, 2018; DeMartini et al., 2019; Kligler et al., 2016; van Dis et al.,
2020). Exercise is also an easy and beneficial recommendation to reduce anxiety and improve
overall health (Aylett et al., 2018; Kligler et al., 2016). Standard pharmacological treatments
such as SSRIs, SNRIs, and CBT are recommended as part of an integrative approach to
treatment options. Benzodiazepines should be utilized with caution and be reserved for asneeded use for panic attacks and or quality of life issues if other therapies are not successful.
Buspirone and propranolol could also be recommended for anxiety-relieving properties
(Bandelow et al., 2015; DeMartini et al., 2019; Stahl, 2021).
However, many of these standard treatments were less effective than desired to relieve
anxiety and might exhibit side effects some patients found intolerable. A literature review
suggested an integrative treatment approach for adults with anxiety holds promise with some
modalities having efficacy equal to standard treatments and with far fewer side effects.
Ashwagandha, chamomile, magnesium, valerian, and passionflower could be recommended as
treatments based on evidence of efficacy and low levels of reported adverse effects (Borrás et al.,
2021; Boyle et al., 2017; Gibbert et al., 2017; Hieu et al., 2019; Lopresti et al., 2019; Noah et al.,
2021; Rycroft-Malone & Tsai, 2018; Shinjyo et al., 2020). Meditation, biofeedback, and
relaxation could be recommended based on the evidence of no known adverse effects and the
benefit of reduction in anxiety symptoms (Arizteca et al., 2017; Bandelow et al., 2015; Goessl et
al., 2017; Kim & Kim, 2018; Saeed et al., 2019). L-Theanine (Hidese et al., 2019; Sarris et al.,
2019) and omega-3 polyunsaturated fatty acids (Deane et al., 2021; Su et al., 2018) were often
used for the treatment of anxiety but were not sufficiently supported by the evidence to warrant
recommendation. Chamomile and magnesium could benefit from higher-quality studies to
determine their use as an integrative approach to treatment of anxiety as they demonstrated
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relatively low rate of side effects but their efficacy has yet to be determined. Chamomile has
been used and recognized as a beneficial herb for decades, while magnesium is an essential
vitamin deficient in much of the adult population (Hieu et al., 2019; Rycroft-Malone & Tsai,
2018).
Overall, the evidence suggested conventional methods alone were not enough to alleviate
symptoms of adult anxiety (Garakani et al., 2020). By blending conventional and alternative/
complementary methods (the basis of integrative care) and offering a wider range of treatments
to a diverse adult population with anxiety, it is possible more adults would find relief from
anxiety symptoms. Integrative care embraces the complexity and nature of the human being to
promote wellness and a whole-person approach to treating anxiety (Kreitzer & Koithan, 2019).
Many mental health providers have not been educated on use of these treatment options and
might have hesitancy in prescribing these to patients with anxiety (Arizteca et al., 2017; Aylett et
al., 2018; Bandelow et al., 2015; Borrás et al., 2021; Boyle et al., 2017; Daitch, 2018; Deane et
al., 2021; DeMartini et al., 2019; Garakani et al., 2020; Gibbert et al., 2017; Goessl et al., 2017;
Hidese et al., 2019; Hieu et al., 2019; Kim & Kim, 2018; Kligler et al., 2016; Kreitzer &
Koithan, 2019; Lopresti et al., 2019; Noah et al., 2021; Rycroft-Malone & Tsai, 2018; Saeed et
al., 2019; Sarris et al., 2019; Su et al., 2018; Shinjyo et al., 2020; van Dis et al., 2020).
Theoretical Framework
Maureen Dobbins’ framework, the dissemination and use of research evidence for policy
and practice (DUREPP), was developed in 2002 “to provide a guiding map to individuals and
organizations in the health care field to assist them in achieving evidenced-based informed
decision making” (Rycroft-Malone & Bucknall, 2010, p. 147). According to Dobbins et al.
(2002), there have been significant delays in translating evidence to practice and this framework
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attempts to address that process. The framework underwent updates in 2004 and 2005 (Dobbins,
2007; Rycroft-Malone & Bucknall, 2010). Using the underpinnings of Rogers’ diffusion of
innovation theory developed in the mid-1990s, Dobbin’s framework addressed the delays in
transitioning evidence into practice by implementing evidence-based research into practice in a
timely manner (Rycroft-Malone & Bucknall, 2010).
Figure 1 displays a graphic representation of the five phases of this model including
knowledge, persuasion, decision, implementation, and confirmation. Dobbins et al. (2002)
acknowledged the development of this framework was based on the idea that the best evidence
was not being consistently used in practice. As a nurse scientist, Dobbins (2007) created a model
to address this deficiency. The framework expanded on Rogers’ theory by creating a system and
process to efficiently put best evidence into practice. Dobbins’ framework creates a pathway for
implementation to accelerate the process of evidenced-based research into practice (RycroftMalone & Bucknall, 2010). The framework has a flow that is logical and easily utilized to
implement changes. Knowledge takes research that has been done and implementation of this
research starts with the persuasion of the research and its use in the practice. When stakeholders
have been identified, the decision to utilize the research has been made and the process starts.
Implementation is the adoption of the research and evaluation over time if this research created a
positive outcome. Confirmation looks at the findings of the adoption of this new modality and
determine if a worthwhile change has been shown to have positive outcomes with its
implementation (Dobbins, 2007; Rycroft-Malone & Bucknall, 2010).
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Figure 1
Illustration of Dobbins’ Model

Note. Illustration of Dobbin’s model. Permission is granted at no cost for use of content in
master’s thesis and/or doctoral dissertation (Dobbins et al., 2001).

Application to the Project
Phase 1
The first phase, knowledge, is the identification of the gap in clinical practice (Dobbins et
al., 2002). For this scholarly project, the need for an online educational seminar of an integrative
practice for the management of adults with anxiety was identified as a knowledge gap. This gap
was discovered through conversations with the outpatient clinic’s manager as a need for the
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practice. Most providers in the practice do not hold an integrative certification and as such are
not comfortable with recommending or addressing such alternative/complementary treatments
as herbal supplementation or meditation practices. During the COVID-19 pandemic, this need
became more apparent as many patients and most of the providers in the practice were unable to
provide this information. In multiple supervision meetings, which are held bi-weekly, the lack of
knowledge and training in alternative/complementary treatments was a recurrent theme.
Feedback from clients reflected the desire for alternative/complementary treatments but lack of
expertise by many of the providers in the practice led to these treatments not being utilized
(Practice Owner, Psychiatric Mental Health Nurse Practitioner, personal communication, June
2021).
Phase 2
The second phase, persuasion, links the knowledge phase and the decision phase
(Rycroft-Malone & Bucknall, 2010). Dobbins et al. (2002) stated that among the most effective
dissemination techniques were the use of opinion leaders. Thus, the persuasion phase in this
project included both discussion and surveying of organizational clinicians at the project site.
Those with and without integrative knowledge were solicited to attend a voluntary online
educational seminar. While multiple providers in practice hold an integrative nursing
certification for psychiatry, others did not, so communicating the project's overarching goals and
valuing the wide range of opinions was important for the project’s success.
Phase 3
The third phase, decision, and the fourth phase, implementation, were closely linked in
this project. Because the online educational seminar consisted of various advanced practice
nurses with a range of clinical practice expertise, disseminating current evidence to the panel
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helped to increase their knowledge of alternative/complementary treatments for adults with
anxiety that could be used in conjunction with conventional treatments, creating an integrative
care approach (Rycroft-Malone & Bucknall, 2010). Dobbins et al. (2002) discussed the
importance of the individuals within the organization becoming familiar and comfortable with
the possible change and how those individuals’ thoughts, feelings, and knowledge influenced
their decision-making process. Thus, the third phase of the framework focused on furthering the
knowledge and expertise of providers to gain confidence in prescribing alternative and
complementary treatment options for patients with anxiety. In addition, the participants’ attitudes
and feelings about integrative approaches were assessed at the start and end of the project to
gauge if their participation in the online educational seminar impacted their knowledge.
Phase 4
Phase 4, implementation, was closely linked to Phase 3 of this project is it focused on the
development of the online educational seminar intended as a pilot for use as a template for
additional seminars, utilizing alternative/complementary methods that blended with conventional
methods of psychiatric treatments to create a more integrative method of practice in the future.
Phase 5
Phase 5, confirmation, was the last phase in the DUREPP, which focused on evaluation
of the project outcomes (Rycroft-Malone & Bucknall, 2010). For this project, the online
educational seminar was evaluated through conducting pre and post surveys on elements of the
seminar important for prescribing alternative and complementary treatment options for anxiety.
Additionally, a survey to evaluate provider’s overall attitudes toward alternative and
complementary treatment options was also conducted to evaluate for any global changes in
provider’s knowledge and attitudes in using alternative/complementary methods to treat anxiety
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in the adult population. The results of the evaluation phase of the project are presented in
Chapter IV.
Summary
The literature was reviewed and synthesized, and 23 articles were used in the
development of this project. Ashwagandha, chamomile, magnesium, valerian, passionflower,
meditation, biofeedback, relaxation, L-Theanine, omega-3 polyunsaturated fatty acids,
chamomile and magnesium were all reviewed. The strongest evidence and recommendations
included ashwagandha, meditation, chamomile, magnesium, valerian, passionflower, meditation,
biofeedback and relaxation for the treatment of anxiety. L-Theanine and omega-3
polyunsaturated fatty acids did not have sufficient evidence to be recommended for use. Maureen
Dobbins’ framework (DUREPP) was chosen as the framework that helped to develop this quality
improvement educational seminar pilot project. Dobbins et al. (as cited in Rycroft-Malone &
Bucknall, 2010) looked to take best evidence and put it into practice. This project was about
increasing knowledge, looking at provider attitudes toward integrative care, helping to put best
evidence into practice, and the creation of a template for further educational seminars.
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CHAPTER III
METHODOLOGY
Design
Anxiety is a complex mental health disorder that has effects on a global scale.
Conventional treatment options are only partially effective and often come with significant side
effects. Integrative approaches to treatment of anxiety include alternative/complementary
treatment options that accompany conventional approaches but many mental health providers do
not know enough of these options to be comfortable using them in their practice. To meet this
need, this quality improvement project was developed that incorporated an educational seminar
and pre/post examination of knowledge attainment and provider attitudes regarding knowledge
and use of integrative medicine.
Setting
The setting for this quality improvement project was an outpatient mental health private
practice in Denver, Colorado. This setting has 18 advanced practice psychiatric mental health
nurse practitioners with varying degrees of experience in integrative care approaches for the
management of adults with anxiety. This practice setting treats patients across the lifespan (ages
6 to 90+) with an entire scope of psychiatric illness including substance abuse disorders.
Providers in this practice range in experience from 2 years to 30+ years. Several providers also
carry other advanced practice certifications, which bring a vast amount of experience and skill
sets to the practice.
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Sample
The advanced practice providers were approached for participation in the pilot quality
improvement project with an estimated sample size of 12-13. Recruitment consisted of emailing
the advanced practice providers and outlining the DNP project and the role of the voluntary
participant.
Inclusion criteria for the project were:
•

Advanced practice providers employed in the identified outpatient mental health
practice who volunteered to participate in an online educational seminar about
alternative/complementary treatment methods for the treatment of adults with
anxiety

•

Two or more years of experience working as a psychiatric/mental health advanced
practice provider.

Exclusion criteria were:
•

Advanced practice providers with less than two years of experience working as a
psychiatric provider

•

A DNP scholarly project committee member
Mission and Vision of the Quality Improvement Project

The mission was to increase psychiatric mental health nurse practitioners’ knowledge
regarding two alternative/complementary treatments for adults with anxiety and to improve their
attitude toward integrative treatment modalities.
The vision was to incorporate alternative/complementary modalities in the treatment of
adults with anxiety for psychiatric mental health nurse practitioners in a private practice.
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Project Objectives
1.

Synthesize the current literature utilizing expertise from the integrative providers
in an outpatient mental health private practice to develop an online educational
seminar using two alternative/complementary treatments for the adult population
with anxiety
a.

Determine two alternative/complementary treatment methods to present to
advanced practice providers at the identified practice

b.
2.

Conduct a literature review and synthesize the evidence

Develop and conduct an online educational seminar to be given to the advanced
practice providers at the identified private practice
a.

Utilizing the expertise of the advanced practice providers and the literature
review and synthesis conduct an online educational seminar at the identified
private practice

3.

Evaluate the advanced practice providers attitudes, receptivity, knowledge and
understanding toward utilizing integrative treatment approaches for adults with
anxiety before and after participation in the online educational seminar
a.

Development of the pre and post evaluation questionnaire consistent with
Blooms taxonomy method of teaching and learning that would evaluate if
the objectives of increasing knowledge and understanding toward utilizing
integrative treatments approaches for adults with anxiety were met.

b.

The Integrative Medicine Attitude Questionnaire (IMAQ) would be
distributed pre and post evaluation to measure if attitudes toward integrative
practices changed as a result participation in the online educational seminar
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c.

The educational seminar, pre and post evaluation questionnaire, and IMAQ
would be conducted online and independently

4.

Develop a template for further educational seminars to increase and expand
knowledge of integrative treatment methods.
a.

A template for continued educational expansion of alternative/
complementary would be based on the outcomes of this online educational
seminar.
Project Plan

1.

Obtain written permission from the project site to conduct the project with the
relevant staff

2.

Using the literature synthesis and expert opinion, create an education seminar for
adults with anxiety using alternative/complementary treatment methods

3.

Develop pre and post evaluations using Qualtrics software

4.

Submit proposal for review and approval to doctoral scholarly project committee

5.

Once approved by the doctoral scholarly project committee, submit the proposal
to the University of Northern Colorado Institutional Review Board (IRB) for
approval

6.

Recruit participants for the online educational seminar and inclusion and
exclusion criteria via email including soliciting consent to participate

7.

The IMAQ questionnaire and pre and post evaluation are distributed to the
participants one week before and one week after the online education seminar

8.

Data from the pre and post evaluations would be analyzed using SPSS software

9.

Dissemination of results.
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Instrumentation
Integrative Medicine Attitude
Questionnaire
The Integrative Medicine Attitude Questionnaire (IMAQ; see Appendix C) was used to
measure advance practice providers' attitudes regarding use of alternative/complementary
treatment options. The IMAQ is a 29-question reverse 7-point Likert scale with response choices
including absolutely disagree (1) to absolutely agree (7). Item numbers 1, 2, 4, 6, 7, 8, 10, 11,
13, 17, 18, 25 and 27 were reverse coded. Example items included “healing is not possible when
a disease is incurable” and “the spiritual beliefs and practices of patients play no important role
in healing” (Schneider et al., 2003).
The IMAQ was created from a focus panel of faculty, fellows, visiting residents, and
medical students at an integrative based university program. Attitudes were measured based on
provider and students’ integrative medicine values as attitudes are critical to predicting how a
provider would practice medicine (Schneider et al., 2003).
Previously, the questionnaire demonstrated good reliability and validity with a reported
Cronbach’s alpha of .89 (Schneider et al., 2003). The IMAQ was also distributed along with the
pre and post seminar evaluations to determine if the educational seminar led to a change in
attitude toward the use of integrative treatment methods (Schneider et al., 2003).
Education Seminar Pre and
Post Evaluation
Bloom’s taxonomy was used as a guideline to help in the development of the online
educational seminar as well as the development of the pre and post evaluation questionnaire.
Bloom’s taxonomy was originally developed in 1956 to create a “framework for learning,
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teaching and educational achievement in which one level depends on the one below” (Persaud,
2021, p. 1).
Pre and post evaluations examined whether the educational seminar was effective in
increasing knowledge among the providers at the private practice and identifying any needed
revisions for the final template to be developed for further use of the practice. The evaluation
was developed by this author and piloted for grammatical and content clarity by peer feedback
from a pilot pre and post evaluation tests. The pre and post evaluations as well as the IMAQ
were designed and distributed online using Qualtrics Survey Software and the seminar itself
was conducted online. The final copy of the evaluation is provided in Appendix D.
Education Seminar
In consultation with expert integrative providers at the practice setting for this project,
two treatments were chosen for this educational seminar. The complementary/alternative
treatment options were chosen based on current evidence, efficacy of the modalities, and ease of
implementation and learning of the treatment options. The seminar began with a rounded
introduction into integrative therapies in general and then described the two chosen
complementary/alternative therapies of ashwagandha and meditation.
Ashwagandha is a supplement that demonstrates efficacy for the treatment of adult
anxiety; it is easy to use and straightforward to prescribe. Contraindications and side effects of
ashwagandha use were explained and detailed in the seminar. Ashwagandha can be used safely
in most cases. Coordination with primary care might be needed for clients who are treated for
diabetes or hypertension. Ashwagandha can lower blood sugar and blood pressure and
adjustments in pharmaceuticals might be appropriate. Those with thyroid disorders would also
need primary care coordination as ashwagandha could cause an increase in thyroid levels.
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Absolute contraindications included those taking immunosuppressants and pregnant or lactating
cis-gender females. Ashwagandha might need to be held prior to surgical procedures (Kuhn &
Winston, 2008).
Mindfulness-based meditation is something prescribers could easily learn to do and
educate their clients for use at home or work that can help with the reduction of anxiety.
Mindfulness-based meditation carries no risks. Due to the vast number of complementary/
alternative treatments available, only two options were chosen for the seminar to give
participants an opportunity to assimilate the material for use in their current practice.
The educational seminar and objectives were developed to educate providers on the
history of integrative medicine and how alternative/complementary treatments could be safe and
effective with proper training and knowledge. The two chosen treatments were explored in the
seminar in depth with supporting evidence as well as case study presentations to aid in
appropriate use and precautions that should be considered when recommending these two
treatments. Levels of evidence, as well as the how to recommend safe and reliable supplements,
were part of the seminar as well. A certified workplace mindfulness facilitator provided a guided
mindfulness-based meditation at the end of the seminar. Providers could easily learn and teach
this meditation to clients and can be used in any setting. The seminar is included in Appendix E
and provider handout is provided in Appendix F, both of which were created by this author.
The learning objectives for the seminar were:
•

Identify two to three common integrative options for adults with anxiety

•

Increase understanding and awareness of integrative care

•

Identify ashwagandha and mindfulness meditation as integrative therapeutic
options when caring for clients with anxiety
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•

Identify five contraindications and potential side effects of ashwagandha

•

Report increased attitude toward use of alternative/complementary treatments
Analysis

The objectives for the analysis of this project were to determine if an online educational
seminar could improve identification, increase awareness and knowledge of at least two
alternative/complementary treatments, and increase attitudes toward integrative medicine.
Collecting pre and post evaluation data assessed if this educational seminar was able to meet
these objectives. Qualtrics software was used and data from pre and post evaluations as well as
the IMAQ were exported into SPSS for data analysis.
Data analysis procedures for this project were as follows:
•

Demographic data included age, gender, years of experience, certifications, and
any formal integrative knowledge and training. The data were analyzed using
descriptive statics to include percentages. Demographic data were only included
in the pre evaluation

•

Responses from the pre and post evaluations were exported from Qualtrics into
SPSS and data were analyzed using mean and paired t-test to compare items 4, 5,
6, 8, 9, 10, 11, 12 for evaluation of learning objectives

•

Nonparametric tests to include Wilcoxon Signed Rank test were used due to nonnormal distribution of the data

•

The IMAQ was analyzed using sum of all questions and a paired t-test analysis to
compare pre and post seminar attitudes toward integrative medicine.
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Duration
The first stage of this project consisted of the development of the online educational
seminar using the relevant literature, creation of a pre and post evaluation questionnaire,
accompanied by the IMAQ in Qualtrics, and defense of the proposal to the scholarly project
committee. Submission to the IRB followed a successful proposal defense. This process was
expected to take three to four weeks to complete. Upon approval from the IRB, recruitment of
the participants in the online educational seminar began and was expected to take no more than
10 days. The next stage, a week prior to the seminar, the IMAQ and pre evaluation questionnaire
were sent out. The panelists had one week after the pre evaluation questionnaire distribution
before the online educational seminar was conducted. One week after the online educational
seminar, the post evaluation as well as the IMAQ were distributed. The project chair and the
primary investigator were estimated to need one to four weeks to review the data and report the
data findings. The completion of the DNP scholarly write-up and a successful oral defense of the
project were expected to take an additional four weeks. In total, this project was completed in 1214 weeks.
Ethics
Permission from the project site (see Appendix G) and IRB approval (see Appendix H)
were completed prior to beginning the DNP scholarly project implementation. Implied electronic
consent was obtained from the participants with receipt of the pre evaluation questionnaire
/IMAQ and the recruitment email (see Appendix I), which included information regarding
participation, participant time commitment, and how their anonymous responses would be
secured and utilized. All data were stored electronically on a password-protected and encrypted
device. Consent to participate was voluntary and could be withdrawn at any time. Results were
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only shared with the project research advisor using the university’s secure servers throughout the
course of the project. There were no anticipated risks for participants with this project other than
a time commitment of 20-30 minutes pre and post evaluation questionnaires/IMAQ but benefits
to the field of advanced practice nursing could include broader use and application of integrative
treatment methods for clients from the creation of an online evidence-based educational seminar
that might help expand treatment options for the adult population with anxiety in the outpatient
setting.
Summary
The setting and sample of this DNP project were an outpatient psychiatric practice with
recruiting of nurse practitioners in the practice. Sampling occurred at one facility after
permission was obtained by the IRB. An online seminar was conducted and pre and post
evaluations were used to determine if there were any changes in attitude and knowledge due to
the seminar.
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CHAPTER IV
RESULTS
Anxiety is a global health problem, which was exacerbated by the pandemic. This quality
improvement pilot project was an online seminar conducted on September 18, 2022 to an
outpatient psychiatric practice to determine if an educational seminar would help to increase
provider knowledge with two integrative treatment techniques and determine if providers’
attitudes regarding integrative care changed due to the online seminar.
Data Collection
Participants were recruited and consents were signed prior to the first round of
evaluations delivered via Qualtrics. The pre seminar evaluation survey and IMAQ were sent one
week prior to the education seminar (September 11, 2022) with a time of one week to complete.
The seminar was conducted online on September 18, 2022. Post seminar evaluations and
Qualtrics were sent one week post seminar (September 25, 2022) with one week to complete.
Data were imported from Qualtrics to Microsoft® EXCEL® spreadsheets for data
analysis with IBM® SPSS software. Not all participants of this quality improvement pilot project
completed all evaluations. Responses were presented to assess for changes in attitudes toward
integrative treatment options and if there was a change in knowledge due to the online seminar
intervention.
Participants
After IRB consent was obtained, participants were recruited via email. Participants were
recruited from one practice site and consents were completed from those who were willing to
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participate. No incentive was given to participate in this DNP project. Eleven participants
consented to be included in the online educational program and participated in the pre seminar
evaluation and IMAQ. Seven participants completed the post seminar evaluation and IMAQ. The
evaluation sample size was as follows: pre seminar evaluation (n = 10), pre seminar IMAQ
evaluation (n = 11), post seminar evaluation (n = 7), and post seminar IMAQ (n = 7). Reminder
emails via Qualtrics were sent out three times during the week-long time frame to complete the
evaluations. All the data collected from pre and post seminar evaluations and IMAQ are
presented in this analysis.
Missing Data
Several missing data points were noted after data collection. No missing data procedures
were completed and all missing data points were left missing. For inferential analysis of the
IMAQ survey results, missing responses were excluded listwise. The two participants with
previous integrative knowledge were also removed from the IMAQ analysis.
Pre Seminar Integrative Medicine Attitude
Questionnaire Results
Demographics
All participants identified as female. Ages ranged from 31 to 70 with a mean age of 50.75
(SD = 11.91). All participants held psychiatric mental health nurse practitioner certifications with
a range of years of clinical practice of 2 to 38 with a mean of 14.92 (SD = 12.74). Of the 11
participants of the pre seminar evaluation and IMAQ surveys, four identified having formal
integrative training. Formal integrative training was defined as having prior training and
experience in the use of integrative medicine.
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Integrative Medicine Attitude
Questionnaire Reliability
Analysis
Integrative Medicine Attitude Questionnaire scale reliability was evaluated using
Cronbach’s alpha. Pre and post seminar IMAQ surveys demonstrated high levels of internal
consistency (pre seminar α = .801, post seminar IMAQ α = .862).
Pre and Post Seminar Evaluation Data
Fourteen questions were in the pre and post seminar evaluations. A 7-point Likert Scale
with 1 = strongly disagree and 7 = strongly agree was used for 12 of the questions and two were
multiple answer. The pre seminar evaluation analyzed participants’ knowledge of two integrative
techniques, ashwagandha use and mindfulness meditation, as potential interventions in the
treatment of anxiety (see Tables 1-4).
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Table 1
Pre and Post Seminar Evaluation Data
Item

1

2

3

4

5

Strongly
Disagree

Disagree

Somewhat
Disagree

Neither
Agree nor
Disagree

Somewhat
Agree

Agree

Strongly
Agree

M

(1)
1

(2)
3

(3)
2

(4)
1

(5)
3

(6)
0

(7)
0

(± SD)
3.20 (± 1.48)

0

3

2

1

1

0

0

3.00 (± 1.16)

Pre seminar
(n = 11)
Post seminar
(n = 7)

0

3

2

4

1

0

0

3.30 (± 1.06)

0

3

2

1

1

0

0

3.00 (± 1.16)

Pre seminar
(n = 11)
Post seminar
(n = 7)

1

1

2

5

0

0

0

3.50 (± 1.35)

1

0

2

4

0

0

0

3.29(± 1.13)

Pre seminar
(n = 11)
Post seminar
(n = 7)

0

1

3

0

0

5

1

5.40(± 1.35)

0

0

0

0

2

1

4

6.29 (± 0.95)

Pre seminar
(n = 11)
Post seminar
(n = 7)

1

0

2

2

3

2

0

4.20 (± 1.55)

0

0

0

1

2

4

0

5.43 (± 0.78)

Pre seminar
(n = 11)
Post seminar
(n = 7)
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Table 1 Continued
Item

6

7

9

11

12

13

14

Strongly
Disagree

Disagree

Somewhat
Disagree

Somewhat
Agree

Agree

Strongly
Agree

M

(3)
1

Neither
Agree nor
Disagree
(4)
2

(1)
0

(2)
2

(5)
3

(6)
2

(7)
0

(± SD)
4.20 (± 1.47)

0

0

0

1

3

3

0

5.29 (± 0.75)

Pre seminar
(n = 11)
Post seminar
(n = 7)

0

1

1

1

4

2

1

4.80 (± 1.48)

0

0

0

2

3

0

2

5.29 (± 1.25)

Pre seminar
(n = 11)
Post seminar
(n = 7)

2

2

1

4

1

0

0

3.00 (± 1.41)

0

0

0

1

5

1

0

5.00 (± 0.57)

Pre seminar
(n = 11)
Post seminar
(n = 7)

0

1

2

0

5

2

0

4.50 (± 1.35)

0

0

1

0

4

2

Pre seminar
(n = 11)
Post seminar
(n = 7)

2

3

1

0

3

1

0

3.20 (± 1.87)

0

0

0

0

4

3

0

4.43 (± 0.54)

Pre seminar
(n = 11)
Post seminar
(n = 7)

1

5

2

1

0

0

1

3.40 (± 2.12)

0

0

0

0

5

2

0

5.29 (± 0.49)

Pre seminar
(n = 11)
Post seminar
(n = 7)

2

4

1

3

0

0

0

2.90 (± 1.66)

1

4

2

0

5.14 (± 0.69)

Pre seminar
(n = 11)
Post seminar
(n = 7)

0

0

0

0

5.00 (± 1.00)
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Table 2
Pre and Post Seminar Evaluation Data: Common Alternative and Complementary Treatment Options for Anxiety

Item
8) Common alt/comp treatment
options for adults with anxiety
include

Magnesium *
(Y/N)

Electroconvulsive Therapy
(ECT)*
(Y/N)

Meditation*
(Y/N)

Serotonin Receptor Uptake
Inhibitors (SSRIs)
(Y/N)

Pre
seminar
(n = 11)

8/2

8/2

10/0

2/8

Post
seminar
(n = 7)

7/0

0/7

6/1

0/7

Note. All items denoted with * are correct treatment options.

Table 3
Pre and Post Seminar Evaluation Data: Ashwagandha Contraindications
Someone with anxiety
that has no medical
concerns*
(Y/N)

Item
10) Ashwagandha can
be used safely in the
following cases

Pre seminar
(n = 11)
Post seminar
(n = 7)

9/1

7/0

Note. All items denoted with * are correct options.

Someone who is on
an SSRI*
(Y/N)

Someone who is on
immunosuppressant therapy
(Y/N)

Someone who has a
food allergy to nuts*
(Y/N)

5/5

0/10

2/8

7/0

0/7

3/4
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Table 4
Pre and Post Integrative Medicine Attitude Questionnaire Scores

Item
1
*RV

2
*RV

3

4
*RV

5

Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)

Disagree

Somewhat
Disagree

Neither
Agree nor
Disagree

Somewhat
Agree

Agree

Strongly
Agree

M

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(± SD)

0

1

6

1

2

1

0

3.64
(± 1.21)

0

1

2

2

0

2

0

4.00
(±1.53)

1

1

3

2

1

1

2

4.09
(± 1.97)

0

0

2

3

0

1

1

4.43
(± 1.51)

0

0

0

3

1

6

1

5.45
(± 1.04)

0

0

0

1

2

2

2

5.71
(± 1.11)

0

0

2

5

2

1

1

0

0

1

1

3

2

0

0

2

1

2

5

1

0

4.18
(± 1.33)

0

0

2

1

2

2

0

4.57
(± 1.27)

Strongly
Disagree

4.45
(± 1.21)
4.86
(± 1.07)
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Table 4 Continued
Item
6
*RV

7
*RV

8
*RV

9

10
*RV

Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)

11
*RV

Pre seminar
(n = 11)
Post seminar
(n = 7)

Disagree
(2)

Somewhat
Disagree
(3)

Neither
Agree nor
Disagree
(4)

Somewhat
Agree
(5)

Agree
(6)

Strongly
Agree
(7)

2

0

3

0

0

5

1

0

0

1

1

1

3

0

0

0

0

0

0

3

8

6.73
(± 0.47)

0

0

0

0

1

2

4

6.43
(± 0.79)

0

0

0

4

0

5

2

5.45
(± 1.21)

0

0

0

1

0

3

3

6.14
(± 1.07)

0

0

0

6

0

3

2

0

0

0

0

2

3

2

0

1

1

1

3

3

2

5.09
(± 1.58)

0

2

0

2

1

2

0

4.14
(± 1.68)

0

0

0

0

4

3

4

6.00
(± 0.89)

0

0

0

0

0

5

2

6.29
(± 0.49)

Strongly
Disagree
(1)

M
(± SD)
4.91
(± 2.02)
4.83
(± 1.60)

5.09
(± 1.30)
6.00
(± 0.82)
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Table 4 Continued
Item
12

13
*RV

14

15

16

17
*RV

18
*RV

Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)

Disagree
(2)

Somewhat
Disagree
(3)

Neither
Agree nor
Disagree
(4)

Somewhat
Agree
(5)

Agree
(6)

Strongly
Agree
(7)

0

0

0

2

2

5

2

0

0

1

0

5

1

6.29
(± 0.49)

0

1

0

3

1

6

0

5.64
(± 1.03)

0

0

0

0

0

5

2

5.86
(± 0.90)

0

0

0

3

6

1

1

5.00
(± 0.89)

0

0

0

1

4

1

6.00
(± 0.63)

0

0

0

1

6

0

4

6.18
(± 0.87)

0

0

0

1

0

3

3

6.14
(± 1.07)

0

0

0

4

3

3

1

5.09
(± 1.04)

1

2

4

0

5.43
(± 0.79)

Strongly
Disagree
(1)

0

0

0

0

0

M
(± SD)
5.00
(± 1.34)

0

0

0

0

1

4

6

6.45
(± 0.69)

0

0

0

0

1

1

5

6.57
(± 0.79)

0

0

0

4

1

4

2

1

0

1

4

1

0

0

5.36
(± 1.21)
5.57
(± 1.27)
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Table 4 Continued
Item
19

20

21

22

23

24

Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)

Disagree
(2)

Somewhat
Disagree
(3)

Neither
Agree nor
Disagree
(4)

Somewhat
Agree
(5)

Agree
(6)

Strongly
Agree
(7)

0

0

0

2

3

5

1

0

0

0

3

2

1

1

5.00
(± 1.16)

0

0

0

0

1

4

6

6.45
(± 0.689

0

0

0

0

2

5

6.71
(± 0.49)

0

0

0

1

2

6

2

5.82
(± 0.87)

0

0

0

0

0

5

2

6.29
(± 0.49)

0

0

0

1

4

3

3

0

0

1

1

0

5

0

0

0

2

2

6

1

5.55
(± 0.93)

0

0

0

0

0

6

1

6.14
(± 0.38)

0

0

0

0

5

5

1

5.64
(± 0.67)

0

0

0

2

4

1

5.86
(± 0.69)

Strongly
Disagree
(1)

0

0

0

M
(± SD)
5.45
(± 0.93)

5.73
(± 1.01)
6.29
(± 1.25)
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Table 4 Continued
Item
25
*RV

26

27
*RV

28

Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)
Pre seminar
(n = 11)
Post seminar
(n = 7)

Disagree
(2)

Somewhat
Disagree
(3)

Neither
Agree nor
Disagree
(4)

Somewhat
Agree
(5)

Agree
(6)

Strongly
Agree
(7)

0

0

0

4

2

4

1

0

0

0

0

2

5

0

5.71
(± 0.49)

0

0

0

3

2

5

1

5.36
(± 1.03)

0

0

2

2

3

0

5.14
(± 0.90)

0

0

0

2

2

5

2

5.64
(± 1.03)

0

0

0

0

1

6

0

5.86
(± 0.38)

0

0

0

0

4

7

0

0

0

1

0

6

0

Strongly
Disagree
(1)

0

0

Note: All items denoted with *RV are reverse coded for summative scores and inferential statistics.

M
(± SD)
5.18
(± 1.08)

5.64
(± 0.51)
5.71
(± 0.76)
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Integrative Medicine Attitude
Questionnaire Pre/Post
Analysis
Inferential statistics were completed using IBM SPSS for the analysis for any difference
in scores between the pre seminar and post seminar IMAQ surveys. The IMAQ data were tested
for normality for a paired t-test. The results from histogram analysis and Kolmorokov-Smirnov
results for the pre seminar IMAQ (p = 200) and post seminar IMAQ (p = 200) demonstrated nonnormality of the differences in scores from the mean. Because the assumption of data normality
was violated, a non-parametric, Wilcoxon Signed Rank Test was conducted to determine if a
difference existed in median scores between the pre seminar IMAQ and post seminar IMAQ.
The pre and post seminar paired t-test, pre seminar 154.00 (SD =6.640), and post seminar 159.75
(SD =6.98) p=.264 demonstrated no significant difference in scores.
Post Evaluation Quality Improvement
Answers
The post evaluation asked respondents to state the answers to the following questions:
•

What improvement could be added for this and future presentations? Responses
included “None-this was a good presentation,” “Maybe longer and with more
variety of uses,” “Other suggested integrative products!” and “More handouts that
make bullet points to refer to.”

•

What was the biggest take home point? Responses included “Truly good
alternative treatment to anxiety,” “I like that we are looking for more ways to help
with mental health than traditional western medicine,” “Complementary therapies
are helpful,” “How to use Ashwagandha and to ask for help if needed when
discussing best brands and other helpful points,” and “The strong research on the
safety and efficacy of certain supplements for anxiety.”
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Analysis of Study Questions
This DNP scholarly quality improvement pilot project addressed the following questions:
Q1

Will an educational seminar focused on integrative treatment options for anxiety
improve mental health provider’s awareness and knowledge regarding two
common integrative treatment options for adults with anxiety (mindfulness
meditation and ashwagandha)?

Q2

Will participation in the educational seminar on integrative treatment options for
anxiety impact the attitudes and receptivity of mental health providers towards
using integrative approaches in the future with adult patients seeking treatment for
anxiety?

Analysis of data showed the educational seminar increased provider knowledge toward
two integrative treatment options: ashwagandha and mindfulness meditation. Attitudes toward
integrative treatment methods did not show a significant change pre and post educational
seminar.
Summary
This quality improvement pilot seminar was conducted at a private outpatient psychiatry
practice. Participants were asked to complete a pre and post evaluation for a general survey and
the IMAQ. This quality improvement pilot seminar was conducted one week after pre
evaluation. Post evaluation data were collected one week after the seminar and data from pre
and post evaluations of the general survey and IMAQ were analyzed using IBM SPSS software.
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CHAPTER V
DISCUSSION
The purpose of this DNP scholarly quality improvement pilot project was to develop and
conduct an online educational seminar for the integrative treatment of adults with anxiety. This
seminar was created from the synthesis of current evidence-based literature and practice
expertise from other integrative providers in the practice location. The aim of this project was to
evaluate if providers’ attitudes, receptivity, knowledge, and understanding toward integrative
treatment approaches increased after the online educational seminar and if this pilot project could
be used for future practice educational seminars on integrative health techniques for mental
illness.
Project Objectives
Project Objective 1
This objective was to synthesize current evidence and practice expertise from integrative
providers in the outpatient mental health private practice to develop an online educational
seminar of two alternative/complementary treatments for the adult population with anxiety.
To meet this objective, an extensive literature review of integrative treatment approaches
in the treatment of adult anxiety was conducted and synthesized. Integrative providers in the
practice were used to help to narrow down options into two evidence-based treatment techniques
that would be presented to all the providers in an online educational seminar. Evaluation of the
treatments were narrowed down based on two methods that would be valuable treatment options,
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were straightforward, and had little to no side effects. The objective was met and set the stage for
the other objectives of the project.
Project Objective 2
This objective was to develop and conduct an online educational seminar to be given to
the advanced practice providers at the identified private practice.
An educational seminar was created based on the literature review and the seminar was
conducted online on September 18, 2022 via Zoom after an initial invitation and consent to
participate was sent to the potential participants on August 18, 2022. Pre seminar evaluations
were sent out on September 11, 2022, with a time frame of one week to complete. After the
online seminar was conducted, participants were sent another round of the same evaluations one
week later (September 25, 2022) with another deadline of one week to complete. Post
evaluations were completed on October 2, 2022 and data analysis on the evaluations began on
October 3, 2022. Initially 11 providers agreed to participate in the evaluations and seminar and
of those 11, seven completed both pre and post evaluations and the IMAQ. This objective was
met and overall feedback on the presentation, delivery method, and content was overall positive,
setting the stage for future integrative topic presentations.
Project Objective 3
This objective was to evaluate the advanced practice providers’ attitudes, receptivity,
knowledge and understanding toward utilizing integrative treatment approaches for adults with
anxiety before and after participation in the online educational seminar
This project objective was met through a pre and post evaluation to assess for increase in
providers’ knowledge and attitude toward integrative treatments. The IMAQ was used to
evaluate any changes in attitudes toward integrative treatments and the educational seminar
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evaluation surveys were used to determine if there were changes in knowledge. The evaluation
survey consisted of 14 questions with the initial survey identifying demographics to include a deidentified number system for confidentiality, age, gender, years of practice experience, and any
prior integrative knowledge. The post seminar evaluation had the same de-identified number
system and included two short answer questions to assess for provider feedback, constructive
criticism, understanding, and knowledge gained from the presentation. Learning objectives for
the survey and IMAQ are presented in greater detail later in this chapter. This objective furthered
the mission of this DNP quality improvement pilot project: to increase psychiatric mental health
nurse practitioners’ knowledge regarding two alternative/complementary treatments for adults
with anxiety and to improve psychiatric mental health nurse practitioners’ attitudes toward
integrative treatment modalities. Provider attitudes evaluated from the IMAQ did not show a
positive or negative difference in provider attitude toward integrative treatment.
Project Objective 4
This objective was to develop a template for further educational seminars to increase and
expand knowledge of integrative treatment methods.
Questions received post seminar were very positive and many providers asked not only
for more information regarding what was presented during the seminar but other integrative
treatment methods that could be used for mental health diagnosis beyond anxiety. The need for
further educational seminars seemed to be something providers in the practice were wanting to
continue. Some conversations regarding options for depression were a topic most asked for
(Psychiatric mental health nurse practitioner participants in the quality improvement pilot
project, personal communication, October 2022). The certified workplace mindfulness facilitator
who presented during this seminar used this as an introduction for a workplace mindfulness
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workshop she hosted weekly for one hour at lunch time for six weeks beginning October 27,
2022. This positive feedback led to the use of this pilot project as a template for future
integrative care topics.
Seminar Learning Objectives
Seminar Learning Objective One
This objective was to identify two to three common integrative options for adults with
anxiety. Question 8 on the pre and post evaluation survey asked participants to identify common
alternative/complementary treatment options for adults with anxiety including magnesium,
electroconvulsive therapy (ECT), meditation and SSRIs. The item was included to evaluate the
general knowledge base of participants of alternative and complementary treatment options for
patients with anxiety. Magnesium and meditation were correct responses as the question was
presented as complementary/alternative options. Responses were noted on the pre and post
seminar evaluation for most respondents: Pre seminar results (n = 10) documented that eight
chose magnesium, eight chose ECT, all chose meditation, and two chose SSRIs. Post seminar
results (n = 7) documented that all participants chose magnesium, no participants chose ECT, six
chose meditation, and none chose SSRIs. This objective was met as the participants were able to
choose the complementary/alternative options that were common integrative treatment options
for adults. Electroconvulsive therapy was the third choice that could be seen as alternative and or
traditional treatment so this might account for no one choosing this option. The objective was
met as post seminar all chose magnesium and all but one chose meditation.
Seminar Learning Objective Two
This objective was to increase in understanding and awareness of integrative care. This
objective was also intended to assess if provider comfort regarding integrative treatment methods
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increased due to the educational seminar. Question 4 on the evaluation survey assessed this
objective and was worded as “I understand what is meant by integrative care.” This question
assessed to see if provider understanding of what was meant by integrative care increased. The
pre seminar mean was 5.40 (SD = 1.35) and the post seminar mean increased to 6.29 (SD = .95).
Question 5—"I know how to apply integrative care in my practice when treating adult
clients with anxiety” sought to assess if the seminar increased provider ability to apply
integrative care in clients with adult anxiety if appropriate. The pre seminar mean was 4.20 (SD
= 1.55) and the post seminar mean increased to 5.43 (SD = .78).
Question 6—"I do a good job of identifying adult clients with anxiety that may benefit
from integrative care” was intended to assess if providers could better identify clients with
anxiety that might benefit from integrative methods of care. The pre seminar mean was 4.20 (SD
= 1.47) and the post seminar mean increased to 5.29 (SD = .75). This objective noted a small
increase in mean that we could infer as a positive trend toward increasing knowledge and
understanding of integrative care.
Seminar Learning Objective Three
This objective was to identify ashwagandha and mindfulness meditation as integrative
therapeutic options when caring for clients with anxiety. Upon completion of the seminar, the
post evaluation survey showed an increase in correct responses for items 9, 11, and 12, which
were developed to assess for changes post seminar in the ability of participants to identify the use
of ashwagandha and meditation for the treatment of anxiety and the overall comfort in
prescribing these therapies. Survey item 9 increased from a mean of 3.00 (SD = 1.41) to 5.00 (SD
= .57) post-survey. Additionally, for item 11, which focused on the comfort in recommending
mindfulness meditation, the mean scores increased from pre seminar 4.5 (SD = 1.35) to 5.00 (SD
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= 1.00) post seminar. Finally, item number 12, which evaluated participant’s comfort in
recommending Ashwagandha to patients with anxiety, increased in score from 3.2 (SD = 1.87) to
4.43 (SD = 0.54) post seminar.
Although inferential statistics were unable to be conducted for this analysis, the results
demonstrated that the participants in this small pilot study showed a small increase in mean that
we could infer as a trend toward increasing knowledge and understanding. It was noted that the
comfort in instruction on meditation only rose slightly and was less than the other items.
Question 10 was incorrectly added in the power point learning objectives as being part of this
objective; however, this question was part of objective four.
Seminar Learning Objective Four
This objective was to identify five contraindications and potential side effects of
ashwagandha. Question 10 on the pre and post evaluation survey asked participants to evaluate
comfort and general knowledge in understanding safety in using ashwagandha. Responses were
noted on the pre and post seminar evaluations for most respondents: Pre seminar results (n = 10)
documented nine participants chose someone with anxiety who has no medical concerns, five
chose someone on an SSRI/SNRI, none chose someone who was on an immunosuppressant, and
two chose someone who had a food allergy to nuts. Post seminar results (n = 7), seven chose
someone with no medical concerns, seven chose someone who was on an SSRI/SNRI, none
chose someone who was on an immunosuppressant, and three chose someone who had a food
allergy to nuts. Comfort in ability to identify safety and contraindications in use of ashwagandha
for people with anxiety increased. Choice three, someone who was on immunosuppressants, was
the incorrect answer and was not chosen pre or post evaluation. This objective was poorly
worded; however, the question as presented to participants was clear as they were asked to
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identify in which cases ashwagandha could be safely used and all were able to recognize that no
one on immunosuppressants should be given anything without scrutiny and consultation with
that person’s medical team. This might be due to general nursing knowledge that someone on
immunosuppressants is closely monitored and even integrative treatment methods must be used
with scrutiny. Additional follow-up with the providers in the practice would be helpful to see
why their comfort with this practice might be less than with the others or if additional questions
or concerns arose after the seminar. This objective was met overall as participants were able to
correctly identify who not to recommend ashwagandha.
Seminar Learning Objective Five
This objective was to report increased attitude toward use of alternative/complementary
treatments. The IMAQ did not demonstrate any significant changes pre and post seminar. Of the
survey’s 28 questions, only questions 11, 14, 15 and 22 demonstrated an increase in scores
correlating with an improvement in attitude toward use of alternative/complementary treatment
options. No other changes in item scores were noted. The overall survey scores also did not
significantly change pre and post seminar paired t-test, pre seminar 154.00 (SD =6.640), and post
seminar 159.75 (SD =6.98) p=.264.
Conclusions
This pilot project seminar, while not being statistically significant due to the small sample
size and inability to run inferential statistics, did have a small increase in mean that we could
infer as a trend toward increasing knowledge and did have clinical relevance in achieving the
goals of providers showing a positive trend toward the increase in knowledge for the two
integrative treatments: ashwagandha and meditation. Provider take-home comments showed an
overall positive reception to this online seminar and its contents. Providers’ attitudes toward
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integrative medicine did not demonstrate any significant changes pre and post seminar as
measured by the IMAQ. While it was hoped the providers with no integrative training would
have a change in scoring regarding attitude, overall scoring showed most of the providers
generally identified with integrative treatment methods. This could be due to the nature of
psychiatry and the underpinnings of the therapeutic relationship developed with clients during
treatment.
Limitations
There were several limitations to this project. The most significant limitation was the
small sample size in this quality improvement pilot project. Recruitment for this DNP project
was specific to one practice site, which limited diversity of providers. Unfortunately, the
recruitment for this DNP quality improvement pilot coincided with the implementation of a new
electronic health record in the practice. This might have hindered participation, particularly in
the post evaluation surveys, as the new electronic health record was implemented the same week
the evaluations were to be completed post seminar. Staff reported a high level of stress and
anxiety with many stating they felt overwhelmed due to the implementation of the new process
at the worksite, which possibly accounted for the reduced post seminar participation.
Recommendations for Research
Further research needs to be conducted regarding the evaluation of an increase in
knowledge and attitude toward integrative treatments from educational seminars. This seminar
was conducted online; future research might include a comparison between online and in person
seminars to validate if one modality was superior to the other. Research regarding other
integrative methods of care based on current evidence-based literature and disseminated through
educational seminars should also be considered and evaluated to effectively conclude if this

66
method of knowledge dissemination would be a continued useful resource. The IMAQ to
evaluate provider attitudes toward integrative treatment might be used in settings other than
psychiatry to evaluate if a change in attitude was seen in other disciplines.
Recommendations for Practice
Educational seminars for integrative treatment methods are a viable option to help
increase provider knowledge of integrative treatment methods in psychiatry. Educational
seminars do not require extensive time or commitment for the attendees but the knowledge and
practice tools gained from these seminars might be invaluable tools to help with the treatment of
mental illness. Further pilot seminars could be disseminated to other psychiatry practice and
hopefully to primary care and other disciplines to continue to spread knowledge and awareness
of integrative medicine techniques. As more practices adopt this method of evidence-based
knowledge dissemination, it is hoped that more effective treatments for mental illness will
continue to relieve the global burden of mental illness.
Reflection
Five criteria must be met to achieve the rigor of excellence necessary to meet the
Essentials of the American Association of Colleges of Nursing (2006): Enhance, Culmination,
Partnerships, Implements, and Evaluation (EC as PIE; Waldrop et al., 2014). This DNP scholarly
project met the EC as PIE criteria as follows:
Enhance
The goal of this DNP project was enhancement of knowledge of providers in a small
outpatient psychiatric practice by highlighting two integrative measures to help in the treatment
of anxiety in the adult population. This project has the potential to help clients in the community
have less anxiety, better health outcomes, and quality of life. This project also has the capacity to

67
enhance provider knowledge to broaden the scope of treatment for those who do not respond or
have minimal response to traditional treatment methods (Waldrop et al., 2014).
Culmination
The literature review demonstrated a gap in practice between integrative treatments and
implementation of those treatments. An extensive literature review, based on provider and client
feedback, was done and an educational seminar was built upon this research and feedback. This
DNP project was designed as a quality improvement pilot project intended to further the
education of integrative treatments. It was intended to be sustainable for the foreseeable future
with the goal of continuous knowledge enhancement for the providers with benefit to the clients
(Waldrop et al., 2014).
Partnerships
Stakeholders in this project were the providers of the outpatient psychiatric practice as
well as adult clients with anxiety seeking other treatment options for treatment. This project
utilized an extensive literature review and consultation with providers in the practice who had
integrative knowledge to narrow down two integrative techniques to be presented to the practice.
Knowledge of integrative medicine ranged from very minimal to more extensive (Waldrop et al.,
2014).
Implements
Learning objectives were developed to identify if there were positive increases in
knowledge and comfort with the use of two integrative techniques. With the global COVID-19
pandemic, this project was timely as an increase in anxiety has been seen worldwide and
providers and clients in the practice expressed a greater need for a broader number of treatments
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for anxiety. This project was a pilot for future educational seminars for integrative medicine and
is hoped to continue to address a wider range of mental health diseases (Waldrop et al., 2014).
Evaluation
This DNP project was conducted as a pilot for continuing education within the practice.
This project was designed to help enhance provider knowledge, leading to a more robust
treatment option for adults with anxiety who do not benefit from traditional treatment methods.
Although this study did not yield the intended outcomes in increasing provider attitude, provider
knowledge of two integrative treatments, ashwagandha and mindfulness meditation, was
increased. Continued long-term evaluation of further studies would be needed to assess the true
impact of this DNP pilot project with this project serving as a template by utilizing the positive
and negative data to create more effective seminars over time (Waldrop et al., 2014)
Summary
Anxiety is a global disease that affects a broad number of individuals, which could lead
to a loss of income, decrease in life satisfaction, and could lead to depression and or suicide.
Current anxiety treatments are not effective for everyone and other methods of care should be
considered to help improve outcomes. Development of an educational seminar outlining two
integrative methods of treatment has the capacity to improve client outcomes and enhance
practice for providers by broadening their scope of available treatments based in evidence. This
DNP quality improvement pilot project was successful in the creation of an educational seminar,
which is hoped to be a pilot for future seminars that could continue to aid in the treatment for
those suffering from mental illness. Much can be learned from the negative outcomes, as well as
the positive outcomes, to continue to expand provider knowledge of integrative care.
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Table B.1
Table of Evidence
Author

Purpose/Theory

Design

Setting/Sample

Survey/Instruments

Findings

Implications for DNP
Practice/Limitations

Aylett et al.,
2018

How exercise affects
anxiety
No theory framework
identified

Systematic-Review
and Meta-Analysis

Setting -Mixed
Sample 15 studies
only RCTS used
N=695

DSM V criteria for
any anxiety disorder
is met
Adults over the age
of 18

Exercise does have
efficacy in treating
anxiety over waitlist
methods (CI 95% 0.41) and high
intensity exercise has
an even higher effect
on relieving symptoms
of anxiety (CI 95%0.38)

Exercise has long been a
standard recommendation
for treatment of anxiety
symptoms

Level of Evidence
I

Searches done in
CENTRAL,
MEDLINE and
EMBASE

This study shows exercise in
all forms is efficacious, with
higher intensity workouts
giving an even greater
anxiolytic effect
Limitations
Further studies with exercise
for specific anxiety
disorders as well as intensity
of exercise in reduction in
anxiety

Arizteca et al.,
2017

Measuring anxiety
reduction from
biofeedback in an
academic setting and
its effects on academic
performance
No theory framework
identified

Experimental study
with control group
Level of Evidence
III

Setting Undergraduates at
the University of the
Basque Country
Sample N=233

t-test
Pre and Post exam
scores measured

Biofeedback did show
an improvement in
academic performance
and overall reduction
in anxiety

Biofeedback showed
promise in helping with
anxiety relief and overall
increase in academic
performance
This study had no adverse
events and may be helpful in
reducing anxiety symptoms
and increasing performance
Limitations
Longer studies with more
training time in biofeedback
as well as separating anxiety
from performance
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Purpose/Theory

Design

Setting/Sample

Survey/Instruments

Findings

Implications for DNP
Practice/Limitations

Bandelow et al.,
2015

Comparing treatments
for anxiety for efficacy
Standard treatments
were compared
through a metaanalysis to include
medications and
therapies
No theory framework
identified

Meta-Analysis

Setting -Outpatient
Sample RCTs

Hamilton Anxiety
Scale (HAM-A) for
Generalized Anxiety
Disorder (GAD) and
panic disorder with
or without
agoraphobia (PDA)

Medications showed
greater efficacy in
anxiety reduction then
psychotherapies
among the studies

Gold standard evidencebased treatments for anxiety
This study compared
therapy and medications in
RCTs

Mindfulness and
meditation showed
more efficacy than
CBT either in groups
or individuals

Limitations that the authors
found related to publication
bias in both the drug and the
psychotherapy studies
Drug study data were
shorter length of time than
psychotherapy studies (4
weeks compared to 12
weeks average)

Level of Evidence
I
Random effects
model used to
account for
heterogeneity in the
studies

N=37,333
234 RCTs
Searches done in:
Medline, ISI web of
science, PubMed

Liebowitz Social
Anxiety Scale
(LSAS) for Social
Anxiety Disorder
(SAD)

Some SSRIs
performed better than
others although all
were more effective in
treating anxiety than
the placebo
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Findings

Borrás et al.,
2021

Comparing
complementary
therapies used for
sleep and anxiety
No theory framework
identified

Systematic-Review
Level of Evidence
I

Setting -Outpatient
Sample-Clinical
Trials
Searches done in:
PubMed, Scopus
and Cochrane
Library
Research on 23
plants and herbs

Beck Anxiety
Inventory, Beck
Depression
Inventory, Bf-S,
Defined Intensity
Stressor Simulation,
Hamilton Anxiety
Rating Scale,
International
Classification of
Sleep Disorders,
Insomnia Severity
Index, Leeds Sleep
Evaluation
Questionnaire,
Menopause-Specific
Quality Of Life
Questionnaire,
Pittsburgh Sleep
Quality Index, St.
Mary’s Hospital
Sleep Questionnaire,
Speilberger StateTrait Anxiety
Inventory, Visual
Analogue Scale

3 plants were
concluded as being
efficacious in sleep
and anxiety: valerian,
passionflower and
ashwagandha, with
ashwagandha being
the weakest of the 3

Boyle et al.,
2017

Looking at how
supplementing with
magnesium can affect
anxiety and stress
No theory framework
identified

Systematic-Review
Level of Evidence
I

Setting -Outpatient
Sample 18 studies
N=975
Searches done in:
OVID Medline,
CINHAL,
EMBASE, PsycInfo
and grey literature

Hamilton Anxiety
Scale (HAM-A),
Moos Menstrual
Distress
Questionnaire
(MDQ), Speilberger
State Trait Anxiety
Scale (STAI)

Reduction in HAM-A
scores in most studies
Efficacy compared to
Buspirone in one study
showed no difference
between the two

Doses of magnesium
ranged from 46.4600mg

Implications for DNP
Practice/Limitations
Ashwagandha may be
effective against symptoms
of anxiety
Valerian with hops and
passionflower were the best
producers of clinical results
of anxiety and insomnia in
the clinical trials
Limitations include low
quality studies

Magnesium showed efficacy
in treating anxiety as well as
PMS symptoms and postpartum anxiety
Limitation: No clear dosage
range was established in the
studies for treatment
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Daitch, 2018

Looking at multiple
methods and how they
work for anxiety
reduction to include
Cognitive Behavioral
Therapy, Mindfulness
and Hypnosis

Case Study
Level of Evidence
IV

Setting -Outpatient

Mindfulness,
Hypnosis and CBT
were introduced by
the author over the
course of one 60minute session

Client was able to
recognize stressors and
was able to let her son
attend public-school,
main source of
stressors

Sample -1

On subsequent follow
ups reported that client
continued to improve
and report lessening
anxiety symptoms

Implications for DNP
Practice/Limitations
Small case study, but helpful
in demonstrating that
integrative treatment
approaches did help to
alleviate anxiety in one
client as opposed to the talk
only therapy that she had
been participating in
Limitations
Needing larger studies with
multiple participant

Deane et al.,
2019

To determine efficacy
of Omega-3’s in
treatment of
depression and anxiety
No theory framework
identified

Systematic-Review
and Meta-Analysis
Level of Evidence
I

Setting -Outpatient
Sample N=41,470
for Omega’3’s
N=4837 alphalinolenic acid
N=4997 poly
unsaturated fat
Adult participants
over age 18
Searches done in:
Central, Medline,
EMBASE

Center For
Epidemiological
Studies Depression
Scale, Beck
Depression Inventory
II, General Health
Questionnaire,
Geriatric Depression
Scale

Review showed that
many people take
omega-3 supplements
to improve mental
health
Effects on
supplementation show
little to no effect on
preventing anxiety or
depression symptoms
in the adult population

Most studies showed low to
no risk of bias
Large review and metaanalysis comparing many
studies, those with low level
and higher-level evidence
Limitations include low
quality studies and lack of
standardization across the
studies

DeMartini, 2022

Treatment guidelines
for anxiety in internal
medicine

Treatment guidelines
from the American
College of Physicians
for primary care
providers
Level of Evidence
I

Setting-Treatment
guidelines
Sample- review of
literature from the
American College
of Physicians for
primary care

Generalized Anxiety
Disorder-4 Item
Scale, Generalized
Anxiety Disorder-7
Item Scale, Patient
Health Questionnaire
4

List of standard
treatment therapies
and medications with
proven evidence such
as Cognitive
Behavioral Therapy
(CBT), SSRIs, SNRIs
and benzodiazepines

Standard treatment for
treatment of anxiety from a
treatment guideline
Limitations
Only conventional
treatments were addressed
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Goessl et al,
(2017)

The effects of heart
rate variability (HRV)
biofeedback on the
reduction of symptoms
of anxiety in adults
No theory framework
identified

Random Effects
Meta-Analysis
Level of Evidence
I

Setting- Inpatient
and Outpatient
Sample- 24 RCTS
N=484
Searches for
literature in
PubMed, Psycinfo
and Cochrane
232 studies with
188 exclusions with
a further 8
exclusions for
insufficient data
Adults 18 or older
Both male and
female

Becks Anxiety
Inventory (BAI),
Hospital Anxiety and
Depression Scale
(HADS), State-Trait
Anxiety Inventory
(STAI-T), PTSD
Checklist (PCL-S),
Symptom Checklist
90 Revised,
Perceived Stress
Scale (PSS), Detailed
Assessment Of PTSD
(DAPS), Derogatis
Stress Profile (DSP),
Depression Anxiety
Risk Scale

HRV can be an
effective treatment in
anxiety
Effect size of Hedges
g= 0.81 so risk of bias
is low in the studies

One treatment had
to be HRV
biofeedback, selfreported stress and
or anxiety tools
were used to
measure
Exclusion criteria:
Anyone under the
age of 18 was
excluded
Use of additional
biofeedback
methods other then
HRV were also used
or if the study had a
mix of HRV and
another treatment
method

Outcomes did not
seem to be based on
year, number of
sessions or gender,
possibly supporting
broad range of use of
HRV among those
with symptoms of
anxiety

Implications for DNP
Practice/Limitations
HRV or Biofeedback may
be an effective integrative
treatment to help with
symptoms of anxiety in the
adult population
Limitations
Studies did not report on
specific anxiety disorders
and self-report findings
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Gibbert et al.,
2017

Investigating if
passion flower extract
can relieve stress and
nervousness

Multicenter,
prospective noninterventional study

Setting- Mixed
Sample- N=154

German Health
Interview and
Examination Survey
For Adults (DEGS1),
Resilience 3
Questionnaire,
Euroqual Group
Patient
Questionnaire, Visual
Analog Scale

Reduction of anxiety
and increase in
resilience for patients
with nervousness or
stress

No theory framework
identified

Level of Evidence
III

Average dose of 2.4
tablest of passion
flower extract daily
with most frequent
dose 1 tablet 3 times
a day

P=<0.001 for all
symptoms

Implications for DNP
Practice/Limitations
Passion flower may be a
helpful treatment for adults
with anxiety
Limitations
This larger study would
have benefited from a
control group
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Hidese et al.,
2019

Explore the efficacy of
L Theanine on adults
for anxiety and
cognitive ability

Randomized placebo
control trial

Setting- Recruiting
from websites,
magazines, and
local community
announcements

Japanese Version of
Self-Rating
Depression Scale
(SDS), State-Trait
Anxiety Scale
(STAI), Pittsburgh
Sleep Quality Index
(PSQI) Were Used
For Anxiety,
Depression, And
Sleep Rating
Trail Making Test,
Stroop Test and
Japanese Version of
Brief Assessment Of
Cognition In
Schizophrenia
(BACS) was used to
rate cognition
Fasting venous blood
samples collected at
noon and 1300 day of
eval, week 4, week 6
and week 10 of the
trials
Samples included:
Glucose, Hemoglobin
A1C, CBC, Cortisol
levels and IGG-A
levels measured

L theanine had
statistically significant
improvement in
anxiety

No theory framework
identified

Level of Evidence
II

Sample-N=30
Men and women
Adults aged 18 and
over
Mean age was 48
Screened by a
psychiatrist
Exclusion Criteria:
Previous treatment
of any psychiatric
disorder, severe
illness, or
pregnancy

No statistical
significance in
cognitive function
SDS, STATI, PSQI
(p<0.019, 0.006,
0.013)
Scores decreased after
4 weeks showing short
term benefit from L
Theanine for stress
and anxiety
No significant changes
in blood samples
No adverse reactions
reported

Implications for DNP
Practice/Limitations
L Theanine may be a short
term, safe and effective
treatment in adults with
anxiety
Limitations include a
smaller study, possible bias
regarding consumption of
green tea outside the study.
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Hieu et al., 2019

To determine the
efficacy of chamomile
in the treatment of
GAD, anxiety
symptoms, sleep, and
insomnia

Systematic Review
and Meta-Analysis

Setting- inpatient
and outpatient
Sample- 12 RCTs
N=965

Beck Anxiety
Inventory Scale
(BAI), Beck
Depression Inventory
(BDI), Clinical
Global Impression
Severity (CGI-S),
Edinburgh Postnatal
Depression Scale
(EPDS), Fatigue
Severity Scale (FSS),
Hamilton Anxiety
Rating Scale (HAMA), Insomnia
Severity Index (ISI),
No Report (NR),
Postpartum Fatigue
Scale (PFS),
Psychological WellBeing Score
(PGWB), State
Anxiety Inventory
Scale (SAI), State
Trait Anxiety
Inventory (STAI),
The Pittsburgh
Quality Index Scale
(PSQI), Postpartum
Sleep Quality Scale
(PSQS)

Chamomile can be an
effective treatment for
anxiety and sleep
Improvement of GAD
symptoms in the
studies was evaluated
using GAD 7, HAM
A, BAI, PGWB and
CGI-S

No theory framework
identified

Level of Evidence
I

Adults over the age
of 18
Male and female,
but more females in
the study then males
Males N=200
Female N=765
Chamomile in the
studies could be an
oral supplement,
inhaled, a gel or a
massage oil
Searches in
PubMed, Science
Direct, Cochrane
Central, Scopus,
Google Scholar,
WHO Global Health
Library, ISI Web of
Science, Control
Trials, EMBASE
and clinical
trials.gov
RCTs and quasi
experimental studies
included
No age restriction
(however all were
over the age of 18),
language or date of
publication or place

HAM-A showed
improvement in GAD
SDM -1.43, p=0.007
Risk of bias ranged in
the studies from low to
high

Implications for DNP
Practice/Limitations
Chamomile could be a safe
and affordable integrative
treatment for GAD for short
term intervention for adults
with anxiety
Limitations
In the studies efficacy for
GAD at 2-4 weeks, longer
term, higher quality studies
should be done
More evidence needed for
anxiety symptom
management and insomnia
Some of the studies did have
a high level of bias, and
more studies may be needed
to further support the claims
of efficacy in GAD
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Kim & Kim,
2018

Relaxation therapy and
the effect that it can
have on symptoms of
anxiety

Systematic Review
and Meta-Analysis

Setting- inpatient
and outpatient
Sample-16 RCTs

Beck Anxiety
Inventory Scale
(BAI), Beck
Depression Inventory
(BDI), Hamilton
Anxiety Rating Scale
(HAM-A), Penn
State Worry
Questionnaire
(PSWQ),
Panic/Anxiety
Composite Score
(PACS), Leibowitz
Social Anxiety Scale
(LSAS), Mini Mood
and Anxiety
Symptoms
Questionnaire
(MASQ-AA),
Clinician Severity
Rating (CSR), Social
Interaction Scale
(SIS), Social Phobia
Scale (SPS),
Symptom Check List
90 (SCL-90-R), Fear
Questionnaire (FQ),
State-Trait Anxiety
Inventory Scale
(STAI)

Relaxation therapy can
be an effective and
easy treatment for
anxiety symptoms

No theory framework
identified

Level of Evidence
I

N=856
Adults aged 18 and
older
Male and female
Korean or English
language
Studies were
published between
1988-2014
Relaxation
techniques were
Autogenic Training
(AR) and
Mindfulness-Based
Stress Reduction
(MSBR)
Exclusion Criteria:
Not an original
work, relaxation
therapy combined
with another
technique,
compared relaxation
to a pharmacology
treatment, used
relaxation therapy
as a comparator.

Hedges’ g= 0.62
95% CI: 0.42-0.81
Effect size on anxiety
was robust

Implications for DNP
Practice/Limitations
Relaxation therapy could be
an easy and effective tool to
help those with anxiety
Limitations
Needing studies that help to
combine effects of
medications with addition of
relaxation therapy in helping
symptoms of anxiety
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Kligler et al.,
2016

Review of
complementary and
alternative methods to
treat common
conditions seen in
primary care
No theory framework
identified

Systematic Review
Level of Evidence
I

Setting- mixed
Sample- 37 metaanalysis and RCTs
N=42,264
Searches PubMed,
Cochrane database,
NCCIH database,
Natural Medicines
database, DynaMed

Self-report
questionnaires

Effect size of 0.34,
0.48 and 0.29 in the
RCTS reviewed
Found limited
evidence that anxiety
is effective for
reducing anxiety

Implications for DNP
Practice/Limitations
A study that shows some
benefits to exercise, even if
they are somewhat limited.
Exercise has multiple
benefits for health and is a
way to manage anxiety and
maintain other health
benefits
l
Higher quality studies with
better controls and
instruments should be used
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Lopresti et al.,
2019

To look at the efficacy
of Ashwagandha in
reducing symptoms of
stress, anxiety, and
hormones
No theory framework
identified

Randomized, double
blind, placebocontrolled study
Level of Evidence
II

Setting- outpatient
Sample- N=60
(N=37 males, N=23
females)
General volunteers
who had visited
either of the
healthcare facilities
in the area
60-day study
Ages 18-65
HAM-A of 6-17
Exclusion criteria:
pregnancy or not on a
contraceptive,
lactating women,
allergy to
ashwagandha, acute
narrow angle
glaucoma, prostrate
hypertrophy, heart,
endocrine or renal
disease, any chronic
disease that effects
stress/anxiety,
restrictions of ADLs,
suffered from mental
illness past 6 months,
on any other
herb/supplement or
psychiatric
medication, ETOH or
substance abuse

Hamilton Anxiety
Rating Scale (HAMA),
Depression, Anxiety,
Stress Scale-21
(DASS-21)
Serum cortisol
DHEA-S
Testosterone
CBC-lipid profile for
screening
240mg capsule
ashwagandha vs
placebo capsule

41% reduction in
HAM-A scores in the
treatment group
compared to control
group (p<0.001)
compared to a 24%
reduction in the
control group
(p<0.001)
30% reduction in
DASS-21 in the
treatment group
compared to 10% in
the control group

Implications for DNP
Practice/Limitations
RCT demonstrating efficacy
of ashwagandha in the
treatment of adults with
anxiety
Some limitations are the
study addressed healthy
adults and needing studies
on clients with anxiety
diagnosis
Possibly a longer study in
the future rather than a 60day study
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Noah et al.,
2021

Looking at the
combination of
magnesium and B6
supplements to lower
stress and anxiety in
adults vs magnesium
alone
No theory framework
identified

Post-Hoc analysis of
an RCT
Level of Evidence
II

Setting- outpatient
Sample- N=264
Adults aged 18-50
SD age 31.4 years
Male and female
74% were female
DASS-42>18
indicating severe
stress
Had to have
magnesium levels
considered to be
suboptimal (0.660.84)
2 groups magnesium
(300mg and 30mg)
and B6 or
magnesium only
(300mg)

Depression Anxiety
and Stress Scale
(DASS-42)
Short Form Health
Survey (SF-36)
Magnesium levels

DASS 42 over both
groups improved over
the 8-week study
period
No significant
difference between
groups (P<0.05)
However,
improvement in both
groups in anxiety and
depression
SF-36 showed
improvements in all
categories between
both groups
Most changes
observed first 4 weeks

Rycroft-Malone
& Tsai, 2018

Looking at evidence
for herbal and
botanical treatments
and making practice
recommendations
based on that
Focusing specifically
on chamomile for this
review
No theory framework
identified

Practice
recommendations
from the Journal of
Family Practice
Level of Evidence
I

Setting- mixed
Sample- 2 RCTS and
Meta-analysis
regarding anxiety and
chamomile were
reviewed

Data reviewed from a
controlled clinical
trial and a
randomized double
placebo-controlled
trial of adults

Modest anxiolytic
properties found in
both studies

Implications for DNP
Practice/Limitations
Magnesium with or without
B6 can be an effective tool
to reduce symptoms of
anxiety
Limitations include
There was no control group
in the study
Participants may have taken
other medications which
may or may not have had
effects on magnesium levels

Chamomile is a well-known
herbal remedy for sleep.
Chamomile also has some
anti-anxiety effects in adults
Limitations
Overview of practice
recommendations for
primary care, may benefit
from specific psychiatry
focused studies

94
Table B.1 Continued
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Purpose/Theory

Design

Setting/Sample

Survey/Instruments

Findings

Saeed et al.,
2019

Benefits of
nonmedicinal
therapies such as yoga
and meditation on
anxiety
No theory framework
identified

Review of
Systematic-Reviews
and Meta-Analysis
Level of Evidence
I

Setting -Mixed
Sample –33 RCTS
specific to anxiety
were reviewed
209 studies specific
to mindfulness
meditation were
reviewed

On overview of
meta-analysis and
systematic reviews
shows that yoga,
exercise, and
meditation may be
helpful in reducing
symptoms of anxiety
and depression
No trials showed
harm in using
exercise to help in
reduction of anxiety
symptoms

Meditation has been found
to have a positive effect
on anxiety symptoms with
varying results from
multiple studies
No harm in doing
meditation
Not all studies showed
immediate benefit from
meditation

Schneider et al.,
2003

Research article
regarding
development of the
Integrative Medicine
Attitude
Questionnaire (IMAQ
No theory framework
identified

Research Article
Level of Evidence
I

Setting -Integrative
medicine program
Sample -faculty,
residents, fellows
and medical students
N=111

Development of the
IMAQ
Factor Analysis
Cronbach’s alpha

IMAQ is reliable and
valid in measuring
attitudes toward
alternative/complementary
therapies among providers
and students

Implications for DNP
Practice/Limitations
Meditation is a nonharmful
self-guided at home
therapy that may help with
anxiety symptoms
Limitations: some studies
did not find immediate
benefit which may
discourage those looking
for immediate relief of
anxiety

Use of IMAQ to measure
attitudes of providers
toward CAM before and
after an online educational
seminar
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Setting/Sample

Survey/Instruments

Findings

Shinjyo et al.,
202

Determining
usefulness of Valerian
root in treating sleep
and anxiety

Systematic Review
and Meta-Analysis
Level of Evidence
I

Setting -Mixed
Sample – 60 RCTs
N=6,894
8 studies specific to
reduce anxiety were
reviewed N=535
Searches done in:
PubMed, Science
Direct, Cochrane
Library

Pittsburgh Sleep
Quality Inventory
(PSQI), Epworth
Sleepiness Scale
(ESS), Hamilton
Anxiety Rating Scale
(HAM-A), State
Trait Anxiety
Inventory (STAI)

Several studies found that
Valerian root can be
effective in reducing
anxiety with longer term
use 4 weeks, or for short
term use or PRN for
anxiety
Dose range
Standard Extract 600mg a
day
81.3mg of Valepotriates
Valerian root/rhizome
530mg daily
Valerian extract 1,260 for
3 days for PMS anxiety

Implications for DNP
Practice/Limitations
Valerian seems to have
several anxiolytic qualities
for multiple anxiety
treatments
Limitations
Long term, single dose
placebo-controlled studies
would be helpful to
determine dosing ranges
and larger scale studies
should be done
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Purpose/Theory

Design

Setting/Sample

Survey/Instruments

Findings

Su et al., 2019

Looking at Omega-3s
regarding efficacy
with depression and
anxiety
No theory framework
identified

Systematic-Review
and Meta-Analysis
Level of Evidence
I

Setting -Outpatient
Sample N=1203
19 clinical trials
Mean age 43.7 years
Searches done in:
PubMed, Embase,
ProQuest, Science
Direct, Cochrane
Library, Clinical
Key, Web of
Science and
Clincialtrials.gov

Yale Brown
Obsessive
Compulsive Scale
(YBOC), Profile of
Mood States, State
Trait Anxiety
Inventory, Hamilton
Anxiety Rating
Scale, Gad-7,
Depression, Anxiety
and Stress Scales,
Clinical
Administered PTSD
Scale, Beck
Depression
Inventory, Impact of
Event Scale Revised,
Connors Score
Anxiety Scale,
Neuropsychiatric
Inventory, Test
Anxiety Severity,
Hospital Depression
and Anxiety Scale
and Sub Scale, Child
Behavioral Checklist
Anxiety Scale Mean
dosage of Omega
3=1605.7mg

Treatment with omega-3
PFU may be associated
with a reduction in anxiety
in adults with anxiety
compared to placebo
(p=.01)
Random Effects Model

Implications for DNP
Practice/Limitations
Omega-3 offers many
health benefits and may
help in reduction of anxiety
Limitations are design
study, need for
standardization and higher
quality studies,
heterogeneity of this study
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Purpose/Theory

Design
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Survey/Instruments
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van Dis et al.,
2021

Looking at CBT as
treatment for anxiety
Focusing on long
term efficacy of CBT
No theory framework
identified

Systematic-Review
and Meta-Analysis
Level of Evidence
I

Setting -Outpatient
Sample -69 RCTs
N=4118
Adults
Searches in:
PubMed, PsycInfo,
Embase, Cochrane,
and OpenGrey

Had to use CBT as a
therapy
Independent
screening of records
by researchers, data
pooled using random
effects model
Hedges g was used to
calculate anxiety
symptoms after
treatment

CBT has long been the
standard for anxiety
treatment with adjunctive
medications
CBT helpful up to 12
months after cessation of
therapy
Relapse studies need to be
further done to continue to
look at efficacy of CBT
long term

Implications for DNP
Practice/Limitations
Gold standard evidencebased treatments are
needed to be included in
the integrative protocol for
the practice
This study was one of the
few looking at long term
effects of CBT
Limitations include that
most of the studies were
not of high quality
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Your advanced practice role credentials________________________
Total years in practice in current role: __________________
Clinical specialty:_____________
Absolutely disagree

1

2

3

4

5

6

7 Absolutely agree

1) A patient is healed when the underlying pathological processes are corrected or controlled
2) The providers role is primarily to promote the health and healing of the physical body.
3) Patients whose providers are knowledgeable of multiple medical systems and complementary
and alternative practices (i.e., Chinese, Ayurvedic, Osteopathic, Homeopathic, etc.), in
addition to conventional medicine, do better than those whose physicians are only
familiar with conventional medicine.
4) Providers should warn patients to avoid using botanical medicines (herbs) and dietary
supplements until they have undergone rigorous testing such as is required for any
pharmaceutical drug.
5) It is appropriate for providers to use intuition (“gut feelings”) as a major factor in determining
appropriate therapies for patients.
6) The spiritual beliefs and practices of providers play no important role in healing.
7) The spiritual beliefs and practices of patients play no important role in healing.
8) It is irresponsible for providers to recommend acupuncture to patients with conditions like
chemotherapy-related nausea and vomiting or headache.
9) End of life care should be valued as an opportunity for providers to help patients heal
profoundly.
10) It is not desirable for a provider to take therapeutic advantage of the placebo effect.
11) Healing is not possible when a disease is incurable.
12) Providers knowledgeable of multiple medical systems and complementary and alternative
practices (i.e., Chinese, Ayurvedic, Osteopathic, Homeopathic, etc.), in addition to
conventional medicine, generate improved patient satisfaction.
13) Therapeutic touch has been completely discredited as a healing modality.
14) Providers who model a balanced lifestyle (i.e. Attending to their own health, social, family
and spiritual needs, as well as interests beyond medicine) generate improved patient
satisfaction.
15) Quality of life measures are of equal importance as disease specific outcomes in research.
16) Chiropractic is a valuable method for resolving a wide variety of musculoskeletal problems
(beyond back pain)
17) The providers role is primarily to treat disease, not to address personal change and growth of
patients
18) Massage therapy often makes patients “feel” better temporarily but does not lead to objective
improvement in long-term outcomes for patients.
19) The innate healing capacity of patients often determines the outcome of the case regardless
of
treatment interventions.
20) A strong relationship between patient and provider is an extremely valuable therapeutic
intervention that leads to improved outcomes.
21) Providers who strive to understand themselves generate improved patient satisfaction.
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22) Instilling hope in patients is a provider’s duty.
23) Providers should be prepared to answer patient’s questions regarding the safety, efficacy, and
proper usage of commonly used botanical medicines such as Saw Palmetto, St. John’s Wort,
Valerian, etc
24) Counseling on nutrition should be a major role of the providers towards the prevention of
chronic disease.
25) Providers should avoid recommending botanical medicines based on observations of longterm use in other cultures and systems of healing, because such evidence is not based on
large randomized controlled trials.
26) Osteopathic manipulative therapy is a valuable method for resolving a wide variety of
musculoskeletal problems (beyond back pain).
27) Information obtained by research methods other than randomized controlled trials has little
value to providers.
28) It is ethical for providers to recommend therapies to patients that involve the use of subtle
energy fields in and around the body for medical purposes (i.e. Reiki, Healing touch, Therapeutic
touch, etc.
29) Providers who strive to understand themselves provide better care than those who do not.
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An Introduction to Complementary and Alternative Practices for Adults with Anxiety
Pre Seminar and Post Seminar Survey

Survey Identification
To ensure confidentiality, we are asking you to create a non-descript identifier so we can
compare your responses.
1. Please provide your month and day of birth followed by years in practice (MMDDYY;
example 112007)
_________________
Demographics
The responses to the demographic questions will only be used to describe the participants of the
survey in aggregate. No identifying information will be linked to any responses for reporting
purposes.
2. Which category includes your current age?
a.
18-30 years
b.
30-50 years
c.
50+ years
3. What is your gender identity?
a.
Male
b.
Female
c.
Nonbinary
d.
Transgender male
e.
Transgender female
f.
Not listed
g.
Do not wish to disclose
4. What Advanced Practice RN Certifications do you currently hold? (mark all that apply)
a.
FNP
b.
PMHNP
c.
CNS
d.
AGNP
e.
PNP
f.
WHNP
g.
Other____________________
5. How many years have you practiced as an advanced practice RN?
a.
1-5
b.
5-10
c.
10+
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6. Have you had any formal training regarding alternative/integrative practices for mental
health?
a.
Yes
b.
No
c.
Unknown
d.
Please describe:
*Please Note Demographics Will Only Be Included in Pre Evaluation
Pre-Seminar and Post-seminar Survey Items
Please use the following scale to answer the questions below unless otherwise indicated
Likert Scale 1-7 (1- strongly disagree) (2-agree) (3-somewhat disagree) (4-neither agree or
disagree) (5-somewhat agree) (6-agree) (7-strongly agree)
Conventional treatment methods
1. I am satisfied with conventional treatments in my practice for adults with anxiety
2. Conventional treatments are superior to alternative/complementary treatments for
adults with anxiety
3. Conventional treatments are safer than alternative/complementary treatments for
adults with anxiety
Awareness and understanding of integrative care
4. I understand what is meant by integrative care

5. I know how to apply integrative care in my practice when treating adult clients with
anxiety

6. I do a good job of identifying adult clients with anxiety that may benefit from integrative
care

7. I use integrative practices in my personal life
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8. Common alternative/complementary treatment options for adults with anxiety include
(Check all that apply)
a. Magnesium
b. ECT
c. Meditation
d. SSRIs

Knowledge of contraindications and proper use of integrative techniques for adults with
anxiety
9. I am comfortable with education for adult clients regarding contraindications of
integrative care techniques to treat anxiety
10. Ashwagandha can be used safely in the following cases: Check all that apply
a. Someone with anxiety that has no medical concerns
b. Someone that is on an SSRI or SNRI
c. Someone that is on immunosuppressants
d. Someone that has a food allergy to nuts
11. I am comfortable with instructing clients on mindfulness meditation practices
12. I am comfortable with instructing clients on Ashwagandha use
13. I am comfortable with directing clients to locate and purchase best quality supplements
available

Understanding of literature regarding integrative care to treat adults with anxiety
14. I understand where to find best evidence-based literature regarding integrative
techniques

*Please Note the Short Answer Questions Will Only Be On The Post Evaluation

Short Answer Questions
What was the biggest take home point?

What improvement could be added for this and future presentations?
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Note. This PowerPoint presentation was created by the author.
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APPENDIX F
HANDOUT FOR SEMINAR
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Note. The handouts for the seminar were created by the author.
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APPENDIX H
INSTITUTIONAL REVIEW BOARD APPROVAL
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08/11/2022

Principal Investigator:

Jessica Fynboh

Committee Action:

IRB EXEMPT DETERMINATION – New Protocol

Action Date:

08/11/2022

Protocol Number:

2208041611

Protocol Title:

Development of an educational seminar for the integrative medical
management of adults with anxiety

16
11

Date:

Expiration Date:

80
4

The University of Northern Colorado Institutional Review Board has reviewed your protocol and
determined your project to be exempt under 45 CFR 46.104(d)(701) (702) for research involving

22
0

Category 1 (2018): RESEARCH CONDUCTED IN EDUCATIONAL SETTINGS. Research, conducted
in established or commonly accepted educational settings, that specifically involves normal educational
practices that are not likely to adversely impact students' opportunity to learn required educational content
or the assessment of educators who provide instruction. This includes most research on regular and
special education instructional strategies, and research on the effectiveness of or the comparison among
instructional techniques, curricula, or classroom management methods.
Category 2 (2018): EDUCATIONAL TESTS, SURVEYS, INTERVIEWS, OR OBSERVATIONS OF
PUBLIC BEHAVIOR. Research that only includes interactions involving educational tests (cognitive,
diagnostic, aptitude, achievement), survey procedures, interview procedures, or observation of public
behavior (including visual or auditory recording) if at least one of the following criteria is met: (i) The
information obtained is recorded by the investigator in such a manner that the identity of the human
subjects cannot readily be ascertained, directly or through identifiers linked to the subjects; (ii) Any
disclosure of the human subjects' responses outside the research would not reasonably place the
subjects at risk of criminal or civil liability or be damaging to the subjects' financial standing, employability,
educational advancement, or reputation; or (iii) The information obtained is recorded by the investigator
in such a manner that the identity of the human subjects can readily be ascertained, directly or through
identifiers linked to the subjects, and an IRB conducts a limited IRB review to make the determination
required by 45 CFR 46.111(a)(7).
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